PagerDuty (PD) 10-K 16 Mar 23 2023 FY Annual report Financial data

Cover Page

Cover Page - USD ($) $ in Billions	12 Months Ended
	Jan. 31, 2023	Mar. 14, 2023	Jul. 30, 2022
Cover [Abstract]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Jan. 31, 2023
Current Fiscal Year End Date	--01-31
Document Transition Report	false
Entity File Number	001-38856
Entity Registrant Name	PAGERDUTY, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	27-2793871
Entity Address, Address Line One	600 Townsend St.
Entity Address, Address Line Two	Suite 200
Entity Address, City or Town	San Francisco
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94103
City Area Code	844
Local Phone Number	800-3889
Title of 12(b) Security	Common Stock, $0.000005 par value
Trading Symbol	PD
Security Exchange Name	NYSE
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Entity Shell Company	false
Entity Public Float			$ 2.2
Entity Common Stock, Shares Outstanding		91,360,320
Documents Incorporated by Reference	Information required in response to Part III of Form 10-K (Items 10, 11, 12, 13 and 14) is hereby incorporated by reference to portions of the Registrant’s Proxy Statement for the Annual Meeting of Stockholders to be held in 2023. The Proxy Statement will be filed by the Registrant with the Securities and Exchange Commission no later than 120 days after the end of the Registrant’s fiscal year ended January 31, 2023.
Entity Central Index Key	0001568100
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	FY
Amendment Flag	false

Audit Information

Audit Information	12 Months Ended
	Jan. 31, 2023
Audit Information [Abstract]
Auditor Firm ID	42
Auditor Name	Ernst & Young LLP
Auditor Location	San Francisco, California

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Jan. 31, 2023	Jan. 31, 2022
Current assets:
Cash and cash equivalents	$ 274,019	$ 349,785
Investments	202,948	193,571
Accounts receivable, net of allowance for credit losses of $2,014 and $1,809 as of January 31, 2023 and January 31, 2022, respectively	91,345	75,279
Deferred contract costs, current	18,674	16,672
Prepaid expenses and other current assets	13,350	9,777
Total current assets	600,336	645,084
Property and equipment, net	18,390	18,229
Deferred contract costs, non-current	27,715	26,159
Lease right-of-use assets	13,982	20,227
Goodwill	118,862	72,126
Intangible assets, net	37,224	23,133
Other assets	1,364	1,490
Total assets	817,873	806,448
Current liabilities:
Accounts payable	7,398	9,505
Accrued expenses and other current liabilities	11,804	13,640
Accrued compensation	41,834	35,327
Deferred revenue, current	204,137	162,881
Lease liabilities, current	5,904	5,637
Total current liabilities	271,077	226,990
Convertible senior notes, net	282,908	281,069
Deferred revenue, non-current	4,914	7,343
Lease liabilities, non-current	12,704	20,912
Other liabilities	4,184	3,159
Total liabilities	575,787	539,473
Commitments and contingencies (Note 10)
Redeemable non-controlling interest (Note 3)	1,108	0
Stockholders’ equity:
Common stock, $0.000005 par value per share: 1,000,000,000 shares authorized as of January 31, 2023 and 2022; 91,178,671 and 86,758,380 shares issued and outstanding as of January 31, 2023 and 2022, respectively	0	0
Additional paid-in capital	719,816	616,467
Accumulated other comprehensive loss	(1,592)	(669)
Accumulated deficit	(477,246)	(348,823)
Total stockholders’ equity	240,978	266,975
Total liabilities, redeemable non-controlling interest, and stockholders’ equity	$ 817,873	$ 806,448

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Jan. 31, 2023	Jan. 31, 2022
Statement of Financial Position [Abstract]
Allowance for doubtful accounts	$ 2,014	$ 1,809
Common stock, par value per share (in dollars per share)	$ 0.000005	$ 0.000005
Common stock, shares authorized (in shares)	1,000,000,000	1,000,000,000
Common stock, shares issued (in shares)	91,178,671	86,758,380
Common stock, shares outstanding (in shares)	91,178,671	86,758,380

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Income Statement And Statement Of Comprehensive Income [Abstract]
Revenue	$ 370,793	$ 281,396	$ 213,556
Cost of revenue	70,434	48,361	30,686
Gross profit	300,359	233,035	182,870
Operating expenses:
Research and development	134,876	95,690	64,566
Sales and marketing	195,622	161,624	122,155
General and administrative	99,238	77,432	62,431
Total operating expenses	429,736	334,746	249,152
Loss from operations	(129,377)	(101,711)	(66,282)
Interest income	4,765	2,946	4,232
Interest expense	(5,433)	(5,398)	(9,965)
Other expense, net	(19)	(2,757)	(794)
Loss before benefit from (provision for) income taxes	(130,064)	(106,920)	(72,809)
Benefit from (provision for) income taxes	839	(535)	3,906
Net loss	(129,225)	(107,455)	(68,903)
Net loss attributable to redeemable non-controlling interest	(802)	0	0
Net loss attributable to PagerDuty, Inc.	$ (128,423)	$ (107,455)	$ (68,903)
Net loss per share, basic (in dollars per share)	$ (1.45)	$ (1.27)	$ (0.87)
Net loss per share, diluted (in dollars per share)	$ (1.45)	$ (1.27)	$ (0.87)
Weighted average shares used in calculating net loss per share, basic (in shares)	88,721	84,514	79,614
Weighted average shares used in calculating net loss per share, diluted (in shares)	88,721	84,514	79,614

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Statement of Comprehensive Income [Abstract]
Net loss	$ (129,225)	$ (107,455)	$ (68,903)
Unrealized (loss) gain on investments	(772)	(1,012)	206
Foreign currency translation adjustments	(151)	0	0
Total comprehensive loss	(130,148)	(108,467)	(68,697)
Net loss attributable to redeemable non-controlling interest	(802)	0	0
Foreign currency translation adjustments, attributable to redeemable non-controlling interest	2	0	0
Comprehensive loss attributable to redeemable non-controlling interest	(800)	0	0
Comprehensive loss attributable to PagerDuty, Inc.	$ (129,348)	$ (108,467)	$ (68,697)

Consolidated Statements of Rede

Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid-in Capital	Additional Paid-in Capital Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Income	Accumulated Deficit	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Jan. 31, 2020			77,793,540
Beginning balance at Jan. 31, 2020	$ 307,938		$ 0	$ 487,008		$ 137	$ (179,207)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options and restricted stock agreements, net of repurchases (in shares)			2,908,262
Issuance of common stock upon exercise of stock options and restricted stock agreements, net of repurchases	14,107			14,107
Vesting of restricted stock units, net of shares withheld for employee payroll taxes (in shares)			379,129
Vesting of restricted stock units, net of shares withheld for employee payroll taxes	(8,207)			(8,207)
Vesting of early exercised options	507			507
Equity component of convertible senior notes, net of issuance costs	68,478			68,478
Purchases of capped calls related to convertible senior notes	(35,708)			(35,708)
Shares issued related to a business combination (in shares)			1,499,651
Shares issued related to a business combination	$ 38,936			38,936
Issuance of common stock in connection with the Employee Stock Purchase Program (in shares)	301,842		301,842
Issuance of common stock in connection with the Employee Stock Purchase Plan	$ 5,986			5,986
Stock-based compensation	43,387			43,387
Other comprehensive income (loss)	206					206
Net loss attributable to PagerDuty, Inc.	(68,903)						(68,903)
Ending balance (in shares) at Jan. 31, 2021			82,882,424
Ending balance at Jan. 31, 2021	$ 366,727	$ (61,736)	$ 0	614,494	$ (68,478)	343	(248,110)	$ 6,742
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting Standards Update [Extensible Enumeration]	Accounting Standards Update 2020-06 [Member]
Issuance of common stock upon exercise of stock options and restricted stock agreements, net of repurchases (in shares)			2,603,432
Issuance of common stock upon exercise of stock options and restricted stock agreements, net of repurchases	$ 15,099			15,099
Vesting of restricted stock units, net of shares withheld for employee payroll taxes (in shares)			925,400
Vesting of restricted stock units, net of shares withheld for employee payroll taxes	$ (23,586)			(23,586)
Shares issued related to a business combination (in shares)			2,073
Issuance of common stock in connection with the Employee Stock Purchase Program (in shares)	345,051		345,051
Issuance of common stock in connection with the Employee Stock Purchase Plan	$ 7,742			7,742
Stock-based compensation	71,196			71,196
Other comprehensive income (loss)	(1,012)					(1,012)
Net loss attributable to PagerDuty, Inc.	$ (107,455)						(107,455)
Ending balance (in shares) at Jan. 31, 2022	86,758,380		86,758,380
Ending balance at Jan. 31, 2022	$ 266,975		$ 0	616,467		(669)	(348,823)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options and restricted stock agreements, net of repurchases (in shares)			2,093,724
Issuance of common stock upon exercise of stock options and restricted stock agreements, net of repurchases	10,917			10,917
Vesting of restricted stock units, net of shares withheld for employee payroll taxes (in shares)			1,768,163
Vesting of restricted stock units, net of shares withheld for employee payroll taxes	$ (28,677)			(28,677)
Shares issued related to a business combination (in shares)			62,972
Issuance of common stock in connection with the Employee Stock Purchase Program (in shares)	495,432		495,432
Issuance of common stock in connection with the Employee Stock Purchase Plan	$ 9,875			9,875
Stock-based compensation	111,234			111,234
Other comprehensive income (loss)	(923)					(923)
Net loss attributable to PagerDuty, Inc.	$ (128,423)						(128,423)
Ending balance (in shares) at Jan. 31, 2023	91,178,671		91,178,671
Ending balance at Jan. 31, 2023	$ 240,978		$ 0	$ 719,816		$ (1,592)	$ (477,246)

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands		12 Months Ended
		Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Cash flows from operating activities
Net loss attributable to PagerDuty, Inc.		$ (128,423)	$ (107,455)	$ (68,903)
Net loss attributable to redeemable non-controlling interest		(802)	0	0
Net loss		(129,225)	(107,455)	(68,903)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation and amortization		17,429	8,356	5,270
Amortization of deferred contract costs		19,247	14,923	10,977
Stock-based compensation		109,907	70,033	43,231
Amortization of debt discount and issuance costs	[1]	1,839	1,805	7,808
Noncash lease expense		4,073	4,464	4,398
Tax benefit related to release of valuation allowance		(1,330)	0	0
Other		1,841	3,770	2,518
Changes in operating assets and liabilities:
Accounts receivable		(16,586)	(21,594)	(17,637)
Deferred contract costs		(22,805)	(26,167)	(16,876)
Prepaid expenses and other assets		(2,843)	1,279	(2,022)
Accounts payable		(1,473)	2,901	316
Accrued expenses and other liabilities		(1,444)	(99)	(810)
Accrued compensation		6,147	6,766	11,184
Deferred revenue		37,971	40,252	34,723
Lease liabilities		(5,768)	(5,255)	(4,082)
Net cash provided by (used in) operating activities		16,980	(6,021)	10,095
Cash flows from investing activities
Purchases of property and equipment		(4,637)	(3,457)	(4,038)
Capitalized internal-use software costs		(3,836)	(3,353)	(810)
Business acquisition, net of cash acquired		(66,262)	(160)	(49,656)
Asset acquisition		(1,845)	0	0
Proceeds from maturities of held-to-maturity investments		0	0	28,040
Purchases of available-for-sale investments		(212,210)	(197,093)	(222,042)
Proceeds from maturities of available-for-sale investments		202,625	194,059	189,901
Proceeds from sales of available-for-sale investments		0	27,380	9,285
Net cash (used in) provided by investing activities		(86,165)	17,376	(49,320)
Cash flows from financing activities
Proceeds from issuance of convertible senior notes, net of issuance costs paid of $9,302		0	0	278,198
Purchases of capped calls related to convertible senior notes		0	0	(35,708)
Investment from redeemable non-controlling interest holder		1,908	0	0
Proceeds from issuance of common stock upon exercise of stock options		10,481	15,108	14,098
Proceeds from Employee Stock Purchase Plan		9,875	7,742	5,986
Employee payroll taxes paid related to net share settlement of restricted stock units		(28,677)	(23,586)	(8,207)
Net cash (used in) provided by financing activities		(6,413)	(736)	254,367
Effects of foreign currency exchange rates on cash, cash equivalents, and restricted cash		(168)	0	0
Net (decrease) increase in cash, cash equivalents, and restricted cash		(75,766)	10,619	215,142
Cash, cash equivalents, and restricted cash at beginning of period		349,785	339,166	124,024
Cash, cash equivalents, and restricted cash at end of period		274,019	349,785	339,166
Supplemental cash flow data:
Cash paid for interest		3,594	1,797	1,857
Cash paid for taxes		168	324	4
Non-cash investing and financing activities:
Vesting of early exercised options		0	0	507
Fair value of common stock issued as consideration for a business combination		0	0	38,936
Purchase of property and equipment, accrued but not yet paid		159	2,666	572
Payments related to a business acquisition, accrued but not yet paid		0	0	160
Stock-based compensation capitalized in internal use software		1,320	1,163	156
Unpaid bonus capitalized in internal use software		354	189	0
Receivables for cash in-transit on stock options		$ 436	$ 0	$ 0
[1]During the first quarter of fiscal 2022, the Company early adopted ASU 2020-06 which resulted in the elimination of amortization of debt discount on its 1.25% Convertible Senior Notes (the “Notes”) from February 1, 2021.

Consolidated Statements of Ca_2

Consolidated Statements of Cash Flows (Parenthetical) $ in Thousands	12 Months Ended
	Jan. 31, 2021 USD ($)
Statement of Cash Flows [Abstract]
Issuance of convertible senior notes, issuance costs paid	$ 9,302

Description of Business and Bas

Description of Business and Basis of Presentation	12 Months Ended
	Jan. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Business and Basis of Presentation	Description of Business and Basis of Presentation Description of Business PagerDuty, Inc. was incorporated under the laws of the state of Delaware in May 2010. PagerDuty is a digital operations management platform that manages urgent and mission-critical work for a modern, digital business. PagerDuty collects data and digital signals from virtually any software-enabled system or device and leverages powerful machine learning to correlate, process, and predict opportunities and issues. Using incident response, event management, and automation, the Company brings together the right people with the right information so they can resolve issues and act on opportunities in minutes or seconds from wherever they are. As used herein, “PagerDuty”, “we”, “our”, “the Company” and similar terms include PagerDuty, Inc., unless the context indicates otherwise. Basis of Presentation The accompanying consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and include the results of the Company, its wholly owned subsidiaries, and subsidiaries in which the Company holds a controlling interest. All intercompany balances and transactions have been eliminated upon consolidation. The Company’s fiscal year ends on January 31. References to fiscal 2023, for example, refer to the fiscal year ended January 31, 2023. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make, on an ongoing basis, estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates. The Company’s most significant estimates and judgments involve the period of benefit for amortizing deferred contract costs, the determination of the allowance for credit losses, fair value of acquired assets and assumed liabilities, and estimates related to the Company’s revenue recognition, such as the assessment of performance obligations in the Company’s revenue arrangements and the fair value assigned to each performance obligation, among others. Management bases its estimates on historical experience and on various other assumptions which management believes to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Jan. 31, 2023
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Segment Information The Company manages its operations and allocates resources as one operating segment. The Company’s chief operating decision maker (“CODM”) is its chief executive officer, who reviews financial information presented on a consolidated basis for purposes of making operating decisions, assessing financial performance, and allocating resources. Refer to Note 1 5 , “Geographic Information” for information regarding the Company's long-lived assets and revenue by geography. Revenue Recognition The Company generates revenue primarily from cloud-hosted subscription fees with the majority of its revenue from such arrangements. The Company also generates revenue from term-license software subscription fees. Revenue is recognized when control of these services is transferred to its customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services. The Company accounts for revenue contracts with customers by applying the requirements of Topic 606, which includes the following steps: • Identification of the contract, or contracts, with a customer. • Identification of the performance obligations in the contract. • Determination of the transaction price. • Allocation of the transaction price to the performance obligations in the contract. • Recognition of revenue when, or as, the Company satisfies a performance obligation. Cloud-hosted software subscriptions The Company’s cloud-hosted software subscriptions allow customers to use its cloud-hosted software over the contract period without taking possession of the software. The Company’s cloud-hosted software subscription agreements generally have monthly or annual contractual terms. Revenue related to the Company’s cloud-hosted software subscriptions is recognized ratably over the related contractual term beginning on the date that the Company’s platform is made available to a customer. Access to the platform represents a series of distinct services as the Company continually provides access to, and fulfills its obligation to, the end customer over the subscription term. The series of distinct services represents a single performance obligation that is satisfied over time. The Company recognizes revenue ratably because the customer receives and consumes the benefits of the platform throughout the contract period. Term-license software subscriptions The Company’s term license software subscriptions provide both an obligation to provide access to its on-premise software, which includes both open source and proprietary features, as well as an obligation to provide support and maintenance. The Company’s term-license software subscription agreements generally have annual contractual terms. The Company accounts for the license to the software and support as two separate performance obligations. As the open source software is publicly available at no cost to the customer, the Company has determined that there is no value to be assigned to the open source software in the term-license software subscription arrangements. The proprietary software license represents a promise to provide a license to use functional intellectual property that is recognized at a point in time on the date access to the software is made available to the customer and the term-license software subscription period has begun. The Company has concluded the support is a stand-ready performance obligation that consists of a series of distinct services that are satisfied ratably over time as the services are provided. The Company uses a time-based output method to measure progress because efforts are expended evenly throughout the period given the nature of the promise is a stand-ready service. The Company recognizes support revenue ratably, typically beginning on the start of the contractual term of the arrangement. Cloud-hosted and term license software subscriptions In order to determine the stand-alone selling price, the Company conducts a periodic analysis that requires judgment and considers multiple factors that are reasonably available and maximizes the use of observable inputs that may vary over time depending upon the unique facts and circumstances related to each performance obligation. To have observable inputs, the Company requires that a substantial majority of the stand-alone selling prices for a product offering fall within a pricing range. If a directly observable stand-alone selling price does not exist, the Company estimates a stand-alone selling price range by reviewing external and internal market factor categories, which may include pricing practices, historical discounting, industry practices, service groups, and geographic considerations. The Company believes that these analyses result in an estimate that approximates the price the Company would charge for the performance obligations if they were sold separately. The Company’s cloud-hosted and term-license software subscription arrangements are generally non-cancellable and do not contain refund provisions. The Company bills for monthly cloud-hosted and term-license software subscriptions on a monthly basis and annually in advance for arrangements with terms of one year or more. The price of the cloud-hosted and term-license software subscriptions is generally fixed at contract inception and therefore, the Company’s contracts do not contain a significant amount of variable consideration. As a result, the amount of revenue recognized in the periods presented from performance obligations satisfied (or partially satisfied) in previous periods due to changes in the transaction price was not material. The Company’s revenue excludes sales and other indirect taxes. Accounts Receivable and Related Allowance for Credit Losses Accounts receivable are recorded at the invoiced amount, net of allowances for credit losses. The allowance is based upon historical loss patterns, customer credit quality, the age of each past due invoice, and an evaluation of the potential risk of loss associated with delinquent accounts. The allowance also reflects current market conditions and reasonable and supportable forecasts of future economic conditions. The allowance for credit losses was $2.0 million and $1.8 million as of January 31, 2023 and January 31, 2022, respectively. Activity related to the Company’s allowance for credit losses on accounts receivable was as follows: Amount (in thousands) Balance as of January 31, 2021 $ 1,188 Charged to bad debt expense 1,099 Write-offs, net of recoveries (478) Balance as of January 31, 2022 $ 1,809 Charged to bad debt expense 1,063 Write-offs, net of recoveries (858) Balance as of January 31, 2023 $ 2,014 Deferred Revenue The Company records contract liabilities to deferred revenue when amounts are invoiced in advance of performance. Deferred revenue consists of the unearned portion of customer billings. The Company’s payment terms generally provide for payment within 30 days of the invoice date. Amounts anticipated to be recognized within one year of the balance sheet date are recorded as deferred revenue, current; the remaining portion is recorded as deferred revenue, non-current in the consolidated balance sheets. The Company applied the practical expedient in Topic 606 and did not evaluate contracts of one year or less for the existence of a significant financing component. For contracts with terms of more than a year, the Company has determined its contracts generally do not include a significant financing component as the majority relate to contracts that are billed annually in advance. The primary purpose of the Company’s invoicing terms is to provide customers with simplified and predictable ways of purchasing the Company’s cloud- hosted software subscription, not to receive financing from its customers or to provide customers with financing. Deferred Contract Costs Deferred contract costs consist of sales commissions earned by the Company’s sales force which are considered incremental and recoverable costs of obtaining a contract with a customer. The Company determined that sales commissions that are related to contract renewals are not commensurate with commissions earned on the initial contract. Accordingly, sales commissions for initial contracts are deferred and then amortized on a straight-line basis over a period of benefit that the Company has determined to be four years. The Company determined the period of benefit by taking into consideration its customer contracts, technology, and other factors. Amounts anticipated to be recognized within one year of the balance sheet date are recorded as deferred contract costs, current; the remaining portion is recorded as deferred contract costs, noncurrent in the consolidated balance sheets. Deferred contract costs are periodically reviewed for impairment. Amortization of deferred contract costs is included in sales and marketing expense in the consolidated statements of operations. Deferred contract costs on the Company’s consolidated balance sheets were $46.4 million and $42.8 million as of January 31, 2023 and 2022, respectively. Amortization expense was $19.2 million, $14.9 million, and $11.0 million for the fiscal years ended January 31, 2023, 2022, and 2021, respectively. There was no impairment loss in relation to the costs capitalized for the periods presented. The following table represents a rollforward of the Company’s deferred contract costs: Amount (in thousands) Balance as of January 31, 2021 $ 31,587 Additions to deferred contract costs 26,167 Amortization of deferred contract costs (14,923) Balance as of January 31, 2022 $ 42,831 Additions to deferred contract costs 22,805 Amortization of deferred contract costs (19,247) Balance as of January 31, 2023 $ 46,389 Concentrations of Risk and Significant Customers The Company’s financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents, available-for-sale investments, and accounts receivable. All of the Company’s cash equivalents and investments are invested in money market funds, United States (“U.S.”) Treasury securities, commercial paper, corporate debt securities, or U.S. Government agency securities that management believes to be of high credit quality. The Company’s cash, cash equivalents, and available-for-sale investments are spread across several different financial institutions. No single customer accounted for more than 10% of the total accounts receivable balance as of January 31, 2023 or 2022. No single customer represented 10% or more of revenue for the fiscal years ended January 31, 2023, 2022, or 2021. Cost of Revenue Cost of revenue primarily consists of expenses related to providing the Company’s cloud- hosted software subscription to customers, including personnel expenses for operations and global support, payments to the Company’s third-party cloud infrastructure providers for hosting the Company’s software, payment processing fees, amortization of capitalized internal-use software costs, amortization of acquired developed technology, and allocated overhead costs for facilities, information technology, and other allocated overhead costs. Foreign Currency Translation The functional currency for the large majority of the Company's foreign operations is the U.S. dollar, although the Company has one subsidiary use the local currency as its functional currency for the fiscal year ended January 31, 2023. When a consolidated entity’s functional currency is the local currency, the Company translates the foreign functional currency financial statements to U.S. dollars using the exchange rates at the balance sheet date for assets and liabilities, the period average exchange rates for revenue and expenses, and the historical exchange rates for equity. The effects of foreign currency translation adjustments are recorded in other comprehensive income as a component of stockholders’ equity and the related periodic movements are presented in the consolidated statements of comprehensive loss. Foreign currency transaction gains and losses are included in other income (expense), net, in the consolidated statements of operations for the period. Realized foreign currency transaction gains and losses for the fiscal years ended January 31, 2023, 2022, and 2021 were not material. Cash and Cash Equivalents Cash and cash equivalents consist of cash on hand, highly liquid investments with original maturities of three months or less from the date of purchase, and money market funds. Investments The Company’s investments are classified as available-for-sale and consist of highly liquid investments, primarily commercial paper, corporate debt securities, U.S. Government agency securities, and U.S. Treasury securities. The Company determines the appropriate classification of its investments at the time of purchase and reevaluates such designation at each balance sheet date. The Company periodically evaluates its short-term investments to assess whether those with unrealized loss positions are impaired. The Company considers various factors in determining whether to recognize an impairment charge, including the extent to which the fair value is less than the Company’s cost basis, the financial condition of the issuer and any changes thereto, and the Company’s intent to sell, or whether it is more likely than not that the Company will be required to sell, the investment before recovery of the investment’s amortized cost. If the Company determines that the investment is impaired, an impairment loss is recognized in earnings equal to the difference between the investment’s amortized cost and fair value at such date. Realized gains and losses are reported in other income, net, in the consolidated statements of operations. No impairment charges have been recognized to date. Available-for-sale The Company classifies its available-for-sale investments, including those with stated maturities beyond twelve months, as short-term based on their highly liquid nature and because they represent the investment of cash that is available for current operations. In addition, the Company may sell these investments at any time for use in its current operations or for other purposes, even prior to maturity. The Company's available-for-sale investments are recorded at fair market value each reporting period. Unrealized gains and losses on these available-for-sale investments are reported as a separate component of accumulated other comprehensive income in the accompanying consolidated balance sheet until realized. Related Party Transactions Certain members of the Company’s Board of Directors serve as directors of, or are executive officers of, and in some cases are investors in, companies that are customers or vendors of the Company. The Company recognized revenue from the sales of its product to related parties of $1.3 million, $2.5 million and $1.1 million in the fiscal years ended January 31, 2023, 2022, and 2021, respectively, and billings of $1.8 million, $2.2 million, and $1.1 million in the fiscal years ended January 31, 2023, 2022, and 2021, respectively. Additionally, the Company recognized expenses related to purchases $1.2 million and had $1.1 million in cash disbursements to these companies during the fiscal year ended January 31, 2021. Other related party transactions were not material for the fiscal years ended January 31, 2023, 2022, or 2021. Property and Equipment, Net Property and equipment, net, are stated at cost less accumulated depreciation. Depreciation is recorded using the straight-line method over the estimated useful lives of the respective assets, which is generally three The Company periodically reviews the estimated lives of property and equipment. If the estimated useful life assumption is reduced for any asset, the remaining unamortized balance would be amortized or depreciated over the revised estimated useful life. Research and Development Expense Research and development expenses consist primarily of personnel costs for the Company’s engineering, product, and design teams. Additionally, research and development expenses include contractor fees, depreciation of equipment used in research and development activities, acquisition-related expenses, and allocated overhead costs. Research and development costs are expensed as incurred. Internal-Use Software Costs The Company evaluates costs related to the development of its platform and certain projects for internal use incurred during the application development stage. Costs related to preliminary project activities and post-implementation activities are expensed as incurred and costs related to the application development stage are capitalized. Internal-use software is amortized on a straight-line basis over its estimated useful life, which is generally three years. Management evaluates the useful lives of these assets on an annual basis and tests for impairment whenever events or changes in circumstances occur that could impact the recoverability of these assets. The Company capitalized $4.8 million, $4.7 million, and $1.0 million during the fiscal years ended January 31, 2023, 2022, and 2021, respectively. Business Combinations The Company applies the acquisition method of accounting for business combinations. Under this method of accounting, all assets acquired and liabilities assumed are recorded at their respective fair values at the date of the acquisition. Determining the fair value of assets acquired and liabilities assumed requires management’s judgment and often involves the use of significant estimates and assumptions. These estimates can include, but are not limited to, the cash flows that an asset is expected to generate in the future, the appropriate weighted-average cost of capital, and the cost savings expected to be derived from acquiring an asset. Goodwill, Acquired Intangible Assets, and Impairment of Long-Lived Assets Goodwill. Goodwill represents the excess purchase consideration of an acquired business over the fair value of the net tangible and identifiable intangible assets. Goodwill is evaluated for impairment annually in the fourth quarter, and whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable. Triggering events that may indicate impairment include, but are not limited to, a significant adverse change in customer demand or business climate or a significant decrease in expected cash flows. No impairment charges were recorded during the fiscal years ended January 31, 2023, 2022, or 2021. Acquired Intangible Assets. Acquired intangible assets consist of identifiable intangible assets, primarily developed technology and customer relationships, resulting from the Company’s business acquisition. Intangible assets are recorded at fair value on the date of acquisition and amortized over their estimated useful lives. Impairment of Long-Lived Assets. The carrying amounts of the Company’s long-lived assets, including property and equipment, lease right-of-use assets, capitalized internal-use software, and acquired intangible assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying value of these assets may not be recoverable or that the useful lives are shorter than originally estimated. Recoverability of these assets is measured by a comparison of the carrying amounts to the future undiscounted cash flows the assets are expected to generate. If long-lived assets are considered impaired, the impairment to be recognized equals the amount by which the carrying value of the asset exceeds its fair value. If the Company reduces the estimated useful life assumption for any asset, the remaining unamortized balance would be amortized or depreciated over the revised estimated useful life. Advertising Costs Advertising costs are expensed as incurred and are included in sales and marketing expense. Advertising costs were $7.3 million, $10.6 million, and $10.1 million for the years ended January 31, 2023, 2022, and 2021, respectively. Stock-Based Compensation The Company recognizes compensation expense for all stock-based payment awards, including stock options, restricted stock units (“RSUs”) and performance stock units (“PSUs”), based on the estimated fair value of the award on the grant date. The Company estimates the fair value of stock options issued to employees on the date of grant using the Black-Scholes option pricing model, which is impacted by the estimated fair value of the Company’s common stock, as well as certain assumptions including the expected volatility over the term of the option awards, the expected term of the awards, risk-free interest rates and the expected dividend yield. Assumptions and estimates used in the determination of the fair value of stock options include expected volatility, expected term, risk-free rate, and expected dividend yield. The Company estimates the fair value of RSUs and PSUs at its stock price on the grant date. The Company estimates the fair value of shares to be issued under the employee stock purchase plan (the “ESPP”) on the first day of the offering period using the Black-Scholes valuation model, which is impacted by the estimated fair value of the Company’s common stock, as well as certain assumptions including the expected volatility over the term of the offering period, the expected term of the awards, risk-free interest rates and the expected dividend yield. Assumptions used in the determination of the fair value of the ESPP are the same as those used in the determination of the fair value of the Company’s stock options. The Company generally recognizes compensation expense for employee stock-based payment awards on a straight-line basis over the period during which an award recipient is required to provide services in exchange for the award (generally the vesting period of the award), with the exception of PSUs which are recognized using the accelerated attribution method. The Company accounts for forfeitures as they occur. The fair value of each non-employee stock option is estimated at the date of grant using the Black-Scholes option pricing model and is not remeasured over the vesting term. Assumptions used in valuing non-employee stock options are generally consistent with those used for employee stock options with the exception that the expected term is over the contractual life. Income Taxes The Company accounts for income taxes using the asset and liability method. Under this method, the Company recognizes deferred income tax assets and liabilities for the expected future consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, as well as for net operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using the tax rates that are expected to apply to taxable income for the years in which those tax assets and liabilities are expected to be realized or settled. The Company recognizes the deferred income tax effects of a change in tax rates in the period of enactment. The Company records a valuation allowance to reduce its deferred tax assets to the net amount that it believes is more likely than not to be realized. The Company considers all available evidence, both positive and negative, including historical levels of income, expectations and risks associated with estimates of future taxable income and ongoing tax planning strategies in assessing the need for a valuation allowance. Realization of its deferred tax assets is dependent primarily upon future U.S. taxable income. The Company recognizes income tax benefits from uncertain tax positions only if it believes that it is more likely than not that the tax position will be sustained upon examination by the taxing authorities based on the technical merits of the position. The tax benefits recognized in the financial statements from such uncertain tax positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized upon settlement. Although the Company believes that it has adequately reserved for its uncertain tax positions (including net interest and penalties), it can provide no assurance that the final tax outcome of these matters will not be materially different. The Company makes adjustments to these reserves when facts and circumstances change, such as the closing of a tax audit or the refinement of an estimate. To the extent that the final tax outcome of these matters is different from the amounts recorded, such differences will affect the provision for income taxes in the period in which such determination is made and could have a material impact on its financial position, results of operations, and cash flows. Net Loss Per Share Basic net loss per share is computed by dividing net loss by the weighted-average number of shares of common stock outstanding during the period. Diluted net loss per share is computed by dividing net loss by the weighted-average number of shares of common stock outstanding during the period giving effect to all potentially dilutive securities to the extent they are dilutive. The dilutive effect of potentially dilutive securities is reflected in diluted net loss per share by application of the treasury stock method. Basic and diluted net loss per share of common stock were the same for each period presented as the inclusion of all potential shares of common stock outstanding would have been anti-dilutive. Recently Adopted Accounting Pronouncements In October 2021, the FASB issued Accounting Standard Update No. 2021-08 (“ASU 2021-08”), Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers , which requires that an entity (acquirer) recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606 (Revenue from Contracts with Customers). At the acquisition date, an acquirer should account for the related revenue contracts in accordance with Topic 606 as if it had originated the contracts. The ASU is part of the FASB's simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. The Company early adopted ASU 2022-08 as of February 1, 2022 using the prospective method. The adoption of the standard impacted the accounting for the acquisition of Catalytic, Inc. (“Catalytic”) requiring the Company to measure acquired contract assets and liabilities in accordance with ASC 606. The adoption of ASU 2021-08 did not have a material impact on the consolidated financial statements.

Redeemable Non-Controlling Inte

Redeemable Non-Controlling Interest	12 Months Ended
	Jan. 31, 2023
Noncontrolling Interest [Abstract]
Redeemable Non-Controlling Interest	Redeemable Non-Controlling Interest In May 2022, the Company established a joint venture, PagerDuty K.K, which is a variable interest entity. The Company obtained a 51% controlling interest and has consolidated the financial results of the joint venture. The following table summarizes the activity in the redeemable non-controlling interest for the period indicated below: January 31, 2023 (in thousands) Balance at beginning of period $ — Investment by redeemable non-controlling interest 1,908 Net loss attributable to redeemable non-controlling interest (802) Foreign currency translation adjustments 2 Balance at end of period $ 1,108

Balance Sheet Components

Balance Sheet Components	12 Months Ended
	Jan. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Balance Sheet Components	Balance Sheet Components Cash, Cash Equivalents, and Investments Cash, cash equivalents, and investments consisted of the following: As of January 31, 2023 2022 (in thousands) Cash and cash equivalents Cash $ 67,151 $ 268,091 Money market funds 206,868 73,194 Commercial paper — 5,500 U.S. Treasury securities — 3,000 Total cash and cash equivalents $ 274,019 $ 349,785 Available-for-sale investments U.S. Treasury securities $ 51,387 $ 41,105 Commercial paper 34,798 39,483 Corporate debt securities 108,827 112,983 U.S. Government agency securities 7,936 — Total available-for-sale investments $ 202,948 $ 193,571 The following tables summarize the Company’s investments’ adjusted cost, net unrealized (losses) gains, and fair value by significant investment category as of January 31, 2023 and 2022. Gross realized gains or losses from sales of available-for-sale securities were not material for the fiscal years ended January 31, 2023 and 2022. As of January 31, 2023 Cost Basis Unrealized Loss, Net Recorded Basis (in thousands) Available-for-sale investments U.S. Treasury securities $ 51,400 $ (13) $ 51,387 Commercial paper 34,926 (128) 34,798 Corporate debt securities 110,063 (1,236) 108,827 U.S. Government agency securities 8,000 (64) 7,936 Total investments $ 204,389 $ (1,441) $ 202,948 As of January 31, 2022 Cost Basis Unrealized Loss, Net Recorded Basis (in thousands) Available-for-sale investments U.S. Treasury securities $ 41,147 $ (42) $ 41,105 Commercial paper 39,528 (45) 39,483 Corporate debt securities 113,565 (582) 112,983 Total investments $ 194,240 $ (669) $ 193,571 The following tables present the Company’s available-for-sale securities by contractual maturity date as of January 31, 2023 and 2022: As of January 31, 2023 Adjusted Cost Fair Value (in thousands) Due within one year $ 139,443 $ 138,625 Due between one to five years 64,946 64,323 $ 204,389 $ 202,948 January 31, 2022 Adjusted Cost Fair Value (in thousands) Due within one year $ 154,692 $ 154,455 Due between one to five years 39,548 39,116 $ 194,240 $ 193,571 As of January 31, 2023, there were 81 available-for-sale securities in an unrealized loss position, 21 of which were in a continuous unrealized loss position for the last 12 months. The total unrealized loss related to the 21 securities in an unrealized loss position as of January 31, 2023 was $0.7 million. As of January 31, 2022, there were 69 available-for-sale securities in an unrealized loss position, seven of which were in a continuous unrealized loss position for the last 12 months. The total unrealized loss related to the seven securities was $0.7 million When evaluating investments for impairment, the Company reviews factors such as the extent to which fair value has been below cost basis, the financial condition of the issuer and any changes thereto, and the Company’s intent to sell, or whether it is more likely than not that the Company will be required to sell the investment before recovery of the investment’s amortized cost. No impairment loss has been recorded on the securities included in the tables above, as the Company believes that any decrease in fair value of these securities is temporary and the Company expects to recover at least up to the initial cost of the investment for these securities. The Company has not recorded an allowance for credit losses, as the Company believes any such losses would be immaterial based on the high-grade credit rating for each of its marketable securities as of the end of each period. Property and Equipment, Net Property and equipment, net consisted of the following: As of January 31, 2023 2022 (in thousands) Leasehold improvements $ 15,585 $ 15,392 Computers and equipment 9,426 7,483 Furniture and fixtures 4,730 4,686 Capitalized internal-use software 10,971 6,136 Gross property and equipment (1) $ 40,712 $ 33,697 Accumulated depreciation and amortization (22,322) (15,468) Property and equipment, net $ 18,390 $ 18,229 (1) Gross property and equipment includes construction-in-progress for leasehold improvements and capitalized internal-use software of $6.0 million and $6.9 million that had not yet been placed in service as of January 31, 2023 and January 31, 2022, respectively. The costs associated with construction-in-progress are not amortized until placed in service. Depreciation and amortization expense was $6.8 million, $4.6 million, and $3.8 million for the fiscal years ended January 31, 2023, 2022, and 2021, respectively. The carrying values of capitalized internal-use software were $8.8 million and $5.2 million for the fiscal years ended January 31, 2023 and 2022, respectively. Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following: As of January 31, 2023 2022 (in thousands) Accrued professional fees $ 4,926 $ 3,790 Accrued events 952 463 Accrued hosting and infrastructure 1,384 1,495 Accrued taxes 1,711 1,056 Accrued liabilities, other 2,831 6,836 Accrued expenses and other liabilities $ 11,804 $ 13,640 Accrued Compensation Accrued compensation consisted of the following: As of January 31, 2023 2022 (in thousands) Accrued bonuses $ 15,594 $ 13,480 Accrued compensation, other 26,240 21,847 Accrued compensation $ 41,834 $ 35,327

Fair Value Measurements

Fair Value Measurements	12 Months Ended
	Jan. 31, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements The Company measures its financial assets and liabilities at fair value each reporting period using a fair value hierarchy that prioritizes the use of observable inputs and minimizes the use of unobservable inputs when measuring fair value. A financial instrument’s classification within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Three levels of inputs may be used to measure fair value, as follows: Level 1—Valuations based on observable inputs that reflect quoted prices for identical assets or liabilities in active markets. Level 2—Valuations based on inputs that are directly or indirectly observable in the marketplace. Level 3—Valuations based on unobservable inputs that are supported by little or no market activity. The following tables present information about the Company’s financial assets that are required to be measured or disclosed at fair value using the above input categories: As of January 31, 2023 Level 1 Level 2 Level 3 Total (in thousands) Money market funds $ 206,868 $ — $ — $ 206,868 U.S. Treasury securities — 51,387 — 51,387 Commercial paper — 34,798 — 34,798 Corporate debt securities — 108,827 — 108,827 U.S. Government agency securities — 7,936 — 7,936 Total $ 206,868 $ 202,948 $ — $ 409,816 Included in cash equivalents $ 206,868 Included in investments $ 202,948 As of January 31, 2022 Level 1 Level 2 Level 3 Total (in thousands) Money market funds $ 73,194 $ — $ — $ 73,194 U.S. Treasury securities 3,000 41,105 — 44,105 Commercial paper 5,500 39,483 — 44,983 Corporate debt securities — 112,983 — 112,983 Total $ 81,694 $ 193,571 $ — $ 275,265 Included in cash equivalents $ 81,694 Included in investments $ 193,571 The Company’s assets that are measured by management at fair value on a recurring basis are generally classified within Level 1 or Level 2 of the fair value hierarchy. The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. As of January 31, 2023 and 2022, the Company’s Level 2 securities were valued using inputs other than quoted prices that are directly or indirectly observable in the market, including readily available pricing sources for the identical or comparable securities which may not be actively traded. The carrying amounts of certain financial instruments, including cash held in banks, accounts receivable, and accounts payable approximate fair value due to their short-term maturities and are excluded from the fair value table above. Convertible Senior Notes As of January 31, 2023, the estimated fair value of the Notes was approximately $304.8 million. The fair value was determined based on the quoted price for the Notes in an inactive market on the last trading day of the reporting period and is considered as Level 2 in the fair value hierarchy.

Business Combinations

Business Combinations	12 Months Ended
	Jan. 31, 2023
Business Combinations [Abstract]
Business Combinations	Business Combinations Year ended January 31, 2023 On March 8, 2022, the Company completed the acquisition of Catalytic, a provider of a no-code/low-code workflow automation application. The Company acquired Catalytic for purchase consideration of $68.8 million in cash. The acquisition was accounted for as a business combination and the acquired assets and liabilities were recorded at their preliminary fair values on the acquisition date and any excess was recorded as goodwill. The values assigned to the assets acquired and liabilities assumed may be adjusted during the measurement period of up to 12 months from the date of acquisition as further information becomes available. Any changes in the fair values of the assets acquired and liabilities assumed during the measurement period may result in adjustments to goodwill. As of January 31, 2023, the primary area that remains preliminary relates to the valuation of certain tax-related items. The following table presents the fair values of acquired assets and liabilities recorded in the Company’s consolidated balance sheet as of the acquisition date: (in thousands) Cash and cash equivalents $ 2,506 Accounts receivable and other assets 801 Prepaid and other current assets 841 Intangible assets 21,800 Goodwill 46,736 Accounts payable and other liabilities (408) Deferred revenue (856) Other tax liabilities (1,322) Deferred tax liability (1,330) Total purchase consideration $ 68,768 The goodwill was primarily attributed to the value of synergies created with the Company’s current and future offerings. Goodwill is not deductible for income tax purposes. In connection with the acquisition, the Company recognized a net deferred tax liability for approximately $1.3 million, generated primarily from the difference between the tax basis and fair value of the acquired intangible assets, which increased goodwill. As the Company has a full valuation allowance as of January 31, 2023, the Company recorded an income tax benefit for this net deferred tax liability in the consolidated statement of operations for the fiscal year ended January 31, 2023. Refer to Note 14, "Income Taxes" , for further information. The following table sets forth the components of identifiable intangible assets acquired and their estimated useful lives as of the date of acquisition: Fair Value Useful Life (in thousands) (in years) Developed technology $ 19,200 3 Customer relationships $ 2,600 10 The Company also entered into holdback agreements with the two founders of Catalytic with $3.4 million held back in cash which are subject to the recipients’ continued service with the Company and thus excluded from the purchase price and will be recognized ratably as research and development expense over the original required two-year service period. Subsequent to the acquisition, in the fiscal year ended January 31, 2023, one of the original holdback agreement was amended, resulting in the acceleration of $1.6 million of research and development expense relating to a portion of the holdback agreement. From the date of the acquisition, the financial results of Catalytic have been included in and are immaterial to the Company’s consolidated financial statements. Pro forma revenue and results of operations have not been presented because the historical results are not material to the consolidated financial statements in any period presented. The Company did not complete any other business combinations in the fiscal year ended January 31, 2023. Year ended January 31, 2022

Goodwill and Acquired Intangibl

Goodwill and Acquired Intangible Assets	12 Months Ended
	Jan. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Acquired Intangible Assets	Goodwill and Acquired Intangible Assets The changes in the carrying amount of goodwill for the fiscal years ended January 31, 2023 and 2022 are as follows: Goodwill (in thousands) Balance as of January 31, 2021 $ 72,126 Goodwill resulting from business combination — Balance as of January 31, 2022 $ 72,126 Goodwill resulting from business combination 46,736 Balance as of January 31, 2023 $ 118,862 Intangible assets subject to amortization consist of the following: As of January 31, 2023 Cost Accumulated Amortization Net Weighted Average (in thousands) (in years) Customer relationships $ 24,400 $ (5,319) $ 19,081 7.9 Developed technology 24,800 (8,342) 16,458 2.3 Trademarks 400 (400) — 0.0 Assembled workforce 2,527 (842) 1,685 1.3 Other intangibles, net $ 52,127 $ (14,903) $ 37,224 As of January 31, 2022 Cost Accumulated Amortization Net Weighted Average (in thousands) (in years) Customer relationships $ 21,800 $ (2,907) $ 18,893 8.7 Developed technology 5,600 (1,493) 4,107 3.7 Trademarks 400 (267) 133 0.7 Other intangibles, net $ 27,800 $ (4,667) $ 23,133 For the fiscal years ended January 31, 2023, 2022 and 2021, amortization expense related to intangible assets was $10.2 million, $3.5 million and $1.2 million. As of January 31, 2023, expected amortization expense in future periods is as follows: Year ending January 31, (in thousands) 2024 $ 11,224 2025 10,381 2026 3,858 2027 2,440 2028 2,440 Thereafter 6,881 Total expected future amortization expense $ 37,224

Leases

Leases	12 Months Ended
	Jan. 31, 2023
Leases [Abstract]
Leases	Leases Operating Leases The Company has entered into various non-cancellable operating leases for its office spaces with lease periods expiring between fiscal 2023 and fiscal 2029. The operating lease agreements generally provide for rental payments on a graduated basis and for options to renew, which could increase future minimum lease payments if exercised. Lease right-of-use assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As the leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. The lease right-of-use assets also include any lease payments made and exclude lease incentives such as tenant improvement allowances. The operating leases typically include non-lease components such as common-area maintenance costs. The Company has elected to include non-lease components with lease payments for the purpose of calculating lease right-of-use assets and liabilities, to the extent that they are fixed. Non-lease components that are not fixed are expensed as incurred as variable lease payments. Leases with a term of one year or less are not recognized on the consolidated balance sheet. The Company recognizes lease expense for these leases on a straight-line basis over the lease term. The following tables present information about leases on the consolidated balance sheet. As of January 31, 2023 2022 (in thousands) Assets Lease right-of-use assets $ 13,982 $ 20,227 Liabilities Lease liabilities 5,904 5,637 Lease liabilities, non-current 12,704 20,912 As of January 31, 2023 and 2022, the weighted average remaining lease term was 3.8 years and 4.8 years, respectively. As of January 31, 2023 and 2022, the weighted average discount rate used to determine the net present value of the lease liabilities was 3.7%. The following table presents information about leases on the consolidated statement of operations. Year Ended January 31, 2023 2022 2021 (in thousands) Operating lease expense $ 5,651 $ 5,574 $ 5,769 Short-term lease expense 1,842 756 879 Variable lease expense 1,363 939 1,325 The following table presents supplemental cash flow information about the Company’s leases. Year Ended January 31, 2023 2022 2021 (in thousands) Cash paid for amounts included in the measurement of lease liabilities $ 7,025 $ 6,319 $ 5,416 As of January 31, 2023, remaining maturities of lease liabilities are as follows: Year ending January 31, (in thousands) 2024 $ 6,482 2025 6,402 2026 2,244 2027 1,910 2028 1,967 Thereafter 1,011 Gross lease payments $ 20,016 Less: Imputed interest (1,408) Total $ 18,608

Debt and Financing Arrangements

Debt and Financing Arrangements	12 Months Ended
	Jan. 31, 2023
Debt Disclosure [Abstract]
Debt and Financing Arrangements	Debt and Financing Arrangements Convertible Senior Notes On June 25, 2020, the Company issued $287.5 million in aggregate principal amount of the Notes in a private offering pursuant to an Indenture dated June 25, 2020 (the “Indenture”). The total net proceeds from the debt offering, after deducting initial purchaser discounts and debt issuance costs, paid or payable by the Company, were $278.2 million. The Notes are senior, unsecured obligations of the Company and accrue interest payable semiannually in arrears on January 1 and July 1 of each year, beginning on January 1, 2021, at a rate of 1.25% per year. The Notes will mature on July 1, 2025, unless such notes are converted, redeemed or repurchased earlier. The Notes are convertible into cash, shares of the Company’s common stock or a combination of cash and shares of the Company’s common stock, at the Company’s election in the manner and subject to the terms and conditions provided in the Indenture. Holders of the Notes may convert all or any portion of their Notes at their option at any time prior to the close of business on April 1, 2025, only under the following circumstances: • During any fiscal quarter commencing after the fiscal quarter ended October 31, 2020 (and only during such fiscal quarter), if the last reported sale price of the Company’s common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the conversion price on each applicable trading day; • During the five business day period after any ten consecutive trading day period (the measurement period) in which the “trading price” (as defined in the Indenture) per $1,000 principal amount of Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company’s common stock and the conversion rate on each such trading day; • If the Company calls such Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or • Upon the occurrence of specified corporate events, as noted in the Indenture. On or after April 1, 2025 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders of the Notes may convert all or any portion of their Notes at any time, regardless of the foregoing circumstances. The conversion rate will initially be 24.9507 shares of common stock per $1,000 principal amount of Notes, which is equivalent to an initial conversion price of approximately $40.08 per share of common stock. The conversion rate is subject to adjustment under certain circumstances in accordance with the terms of the Indenture, but will not be adjusted for accrued and unpaid interest. In addition, following certain corporate events that occur prior to the maturity date, the Company will, in certain circumstances, increase the conversion rate for a holder who elects to convert its Notes in connection with a fundamental change, as defined in the Indenture. The Company may not redeem the Notes prior to July 6, 2023. The Company may redeem for cash all or any portion of the Notes, at its option, on a redemption date occurring on or after July 6, 2023 and prior to the 41st scheduled trading day immediately preceding the maturity date, if the last reported sale price of the common stock has been at least 130% of the conversion price for the Notes then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to 100% of the principal amount to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. No sinking fund is provided for the Notes. If the Company undergoes a fundamental change (as defined in the Indenture), holders may require the Company to repurchase for cash all or any portion of their Notes at a fundamental change repurchase price equal to 100% of the principal amount of the Notes to be repurchased, plus any accrued and unpaid interest to, but excluding, the fundamental change repurchase date. The Indenture contains customary terms and covenants, including that upon certain events of default occurring and continuing, the trustee or the holders of at least 25% in aggregate principal amount of the outstanding Notes may declare the entire principal of all the Notes plus accrued and unpaid interest to be immediately due and payable. The Company accounts for the Notes as a single liability in accordance with ASU 2020-06 “Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity”. The carrying amount of the Notes is $282.9 million as of January 31, 2023, with principal of $287.5 million, net of unamortized issuance costs of $4.6 million. The Notes were classified as long-term liabilities as of January 31, 2023. The issuance costs related to the Notes are being amortized to interest expense over the contractual term of the Notes at an effective interest rate of 1.93%. The net carrying amount of the liability component of the Notes as of January 31, 2023 and 2022 is as follows: As of January 31, 2023 2022 (in thousands) Principal $ 287,500 $ 287,500 Less: unamortized issuance costs (4,592) (6,431) Net carrying amount $ 282,908 $ 281,069 Interest expense recognized related to the Notes during the year ended January 31, 2023, 2022, and 2021 is as follows: Year Ended January 31, 2023 2022 2021 (in thousands) Contractual interest expense $ 3,594 $ 3,594 $ 2,157 Amortization of debt discount — — 7,104 Amortization of debt issuance costs 1,839 1,804 704 Total interest expense related to the Notes $ 5,433 $ 5,398 $ 9,965 Capped Call Transactions In connection with the offering of the Notes, the Company entered into privately negotiated capped call transactions (the “Capped Calls”) with certain financial institution counterparties (the “Option Counterparties”). The Capped Calls are generally intended to reduce or offset the potential dilution to the common stock upon any conversion of the Notes with such reduction or offset, as the case may be, subject to a cap based on the cap price. For accounting purposes, the Capped Calls are separate transactions, and not part of the terms of the Notes. The Capped Calls are recorded in stockholders’ equity and are not accounted for as derivatives. The cost of $35.7 million incurred to purchase the Capped Calls were recorded as a reduction to additional paid-in capital in the accompanying consolidated balance sheet. Each of the Capped Calls has an initial strike price of approximately $40.08 per share, subject to certain adjustments, which corresponds to the initial conversion price of the Notes. The Capped Calls have an initial cap price of $61.66 per share, subject to certain adjustments. The Capped Calls cover, subject to anti-dilution adjustments, approximately 7.2 million shares of the Company’s common stock. The Capped Calls are subject to automatic exercise over a 40 trading day period commencing on May 2, 2025, subject to earlier termination under certain circumstances.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Jan. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Contractual Commitments As of January 31, 2023, the Company’s contractual obligations are as follows for the years ending January 31: Operating Lease Obligations (1) Purchase Commitments (2) Senior Convertible Notes (3) Total Year ending January 31, (in thousands) 2024 $ 6,482 $ 38,065 $ 3,594 $ 48,141 2025 6,402 21,846 3,594 31,842 2026 2,244 1,346 289,297 292,887 2027 1,910 — — 1,910 2028 1,967 — — 1,967 Thereafter 1,011 — — 1,011 Total $ 20,016 $ 61,257 $ 296,485 $ 377,758 (1) Represents obligations under non-cancellable lease agreements for the Company’s corporate headquarters and worldwide offices. (2) Primarily relates to contractual third-party services. (3) Includes principal and interest payments. For more information regarding the Company’s convertible senior notes, refer to Note 9 , “Debt and Financing Arrangements” . Legal Matters From time to time in the normal course of business, the Company may be subject to various claims and other legal matters arising in the ordinary course of business. The Company investigates these claims as they arise and accrues estimates for resolution of legal and other contingencies when losses are probable and estimable. The Company is not currently a party to any legal proceedings and does not anticipate any pending or threatened litigation that would be expected to have a material adverse effect on its financial condition, results of operations, or cash flows. Warranties and Indemnification The Company has entered into service-level agreements with a portion of its customers defining levels of uptime reliability and performance and permitting those customers to receive credits if the Company fails to meet the defined levels of uptime. To date, the Company has not experienced any significant failures to meet defined levels of uptime reliability and performance as a result of those agreements and, as a result, the Company has not incurred or accrued any material liabilities related to these agreements in the financial statements. In the ordinary course of business, the Company may agree to indemnify customers, vendors, lessors, business partners, and other parties with respect to certain matters, including, but not limited to, losses arising out of the breach of such agreements, services to be provided by the Company, or from intellectual property infringement claims made by third parties. As permitted under Delaware law, the Company has entered into indemnification agreements with its directors and certain officers and employees that will require us, among other things, to indemnify them against certain liabilities that may arise by reason of their status or service as directors, officers, or employees. No demands have been made upon the Company to provide indemnification under such agreements, and there are no claims that the Company is aware of that could have a material effect on its consolidated balance sheets, consolidated statements of operations and comprehensive loss, or consolidated statements of cash flows.

Deferred Revenue and Performanc

Deferred Revenue and Performance Obligations	12 Months Ended
	Jan. 31, 2023
Revenue from Contract with Customer [Abstract]
Deferred Revenue and Performance Obligations	Deferred Revenue and Performance Obligations The following table presents the changes to the Company’s deferred revenue: Year Ended January 31, 2023 2022 2021 (in thousands) Deferred revenue, beginning of period $ 170,224 $ 129,972 $ 92,569 Billings 408,764 321,648 248,279 Deferred revenue assumed in business combinations 856 — 2,680 Revenue recognized (370,793) (281,396) (213,556) Deferred revenue, end of period $ 209,051 $ 170,224 $ 129,972 Approximately 44%, 44%, and 41% of total revenue recognized in the fiscal years ended January 31, 2023, 2022, and 2021 was from the deferred revenue balance as of January 31, 2022, 2021 and 2020, respectively. As of January 31, 2023, future estimated revenue related to performance obligations for cloud-hosted and term-license software subscriptions with terms of more than one year that are unsatisfied or partially unsatisfied at the end of the reporting periods was approximately $188.0 million. The Company expects to satisfy the substantial majority of these unsatisfied performance obligations over the next 24 months and the remainder thereafter. The Company applied the optional exemption for subscriptions with terms of less than one year.

Common Stock and Stockholders'

Common Stock and Stockholders' Equity	12 Months Ended
	Jan. 31, 2023
Equity [Abstract]
Common Stock and Stockholders' Equity	Common Stock and Stockholders’ Equity The Company has two equity incentive plans: the 2010 Stock Plan (the “2010 Plan”) and the 2019 Equity Incentive Plan (the “2019 Plan”, collectively the “Stock Plans”). Upon completion of the Company’s IPO in April 2019, the Company ceased granting awards under the 2010 Plan, and all shares that remained available for future issuance under the 2010 Plan at that time were transferred to the 2019 Plan. The 2019 Plan superseded and replaced the 2010 Plan. As of January 31, 2023 and January 31, 2022, respectively, the Company was authorized to grant up to 28,881,327 shares and 23,343,378 shares of common stock under the Stock Plans. The Company currently uses authorized and unissued shares to satisfy stock award exercises and settlement of RSUs and PSUs. As of January 31, 2023 and January 31, 2022, there were 13,581,239 shares and 14,185,048 shares available for future issuance under the Stock Plans, respectively. Shares of common stock reserved for future issuance are as follows: January 31, 2023 Outstanding stock options and unvested RSUs and PSUs 15,752,820 Available for future stock option, RSU, and PSU grants 13,581,239 Available for ESPP 2,971,223 Total common stock reserved at January 31, 2023 32,305,282 Stock Option Activity Stock option activity is as follows: Number of Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term Aggregate Intrinsic Value (in thousands) Outstanding at January 31, 2022 8,375,866 $ 9.28 6.1 $ 198,828 Granted 24,882 $ 34.22 Exercised (2,093,704) $ 5.21 Canceled (156,063) $ 15.56 Outstanding at January 31, 2023 6,150,981 $ 10.61 5.3 $ 117,986 Vested as of January 31, 2023 5,538,328 $ 9.23 5.1 $ 113,852 The Company uses the Black-Scholes option-pricing model to estimate the fair value of stock options on the date of grant. The Company accounts for forfeitures as they occur. The following assumptions were used to calculate the fair value of employee stock option grants made during the periods: Year Ended January 31, 2023 2022 2021 Expected dividend yield — — — Expected volatility 47.1% 43.8% - 46.9% 43.0% - 44.1% Expected term (years) 6.1 6.1 3.7 - 6.1 Risk-free interest rate 2.50% 1.04% - 1.35% 0.20% - 0.52% Stock options granted during the fiscal years ended January 31, 2023, 2022, and 2021 had a weighted average grant date fair value of $16.46, $18.26, and $15.16 per share, respectively. The aggregate intrinsic value of stock options exercised during the fiscal years ended January 31, 2023, 2022, and 2021 was $50.8 million, $91.0 million, and $72.1 million, respectively. The intrinsic value for options exercised is the difference between the market value of the stock and the exercise price of the stock option at the date of exercise. As of January 31, 2023, there was approximately $7.6 million of total unrecognized compensation cost related to unvested stock options granted under the Stock Plans, which will be recognized over a weighted average period of 1.7 years. Restricted Stock Units A summary of the Company’s RSU activity and related information is as follows: Number of RSUs Weighted Average Grant Date Fair Value Per Share Outstanding at January 31, 2022 6,028,201 $ 34.77 Granted 6,022,637 $ 30.81 Vested (1,721,589) $ 33.25 Forfeited or canceled (2,316,767) $ 33.26 Outstanding at January 31, 2023 8,012,482 $ 32.55 The fair value of RSUs is based on the fair value of the underlying shares on the date of grant. The Company accounts for forfeitures as they occur. As of January 31, 2023, there was $244.0 million of unrecognized stock-based compensation expense related to unvested RSUs, which is expected to be recognized over a weighted average period of 2.7 years based on vesting under the award service conditions. Performance Stock Units On March 8, 2022, the Compensation Committee of the board of directors of the Company certified the results of PagerDuty’s operating plan for the fiscal year ended January 31, 2022. Based on the results, the PSUs granted in April 2021 (“2021 PSU Awards”) were earned at an attainment of 129%. A summary of the Company’s PSU activity and related information is as follows: Number of PSUs Weighted Average Grant Date Fair Value Per Share Outstanding at January 31, 2022 117,701 $ 41.17 Granted (1) 767,409 $ 32.64 Vested (47,416) $ 41.17 Forfeited or canceled (46,968) $ 40.71 Performance adjustment for 2021 PSU Awards 34,332 $ 41.17 Outstanding at January 31, 2023 825,058 $ 33.27 (1) This amount represents awards granted at 100% attainment. In April 2021, the Company granted PSUs to certain employees of the Company for which the ultimate number of units that will vest are determined based on the achievement of performance at the end of the stated performance period. The performance condition is based on the level of achievement of a Company target related to PagerDuty’s operating plan for fiscal 2022. The PSUs vest over a three-year period, subject to continuous service with the Company. The number of shares of the Company’s stock to be received based on the performance condition can range from 0% to 200% of the target amount. Compensation expense for PSUs with performance conditions is measured using the fair value at the date of grant and recorded over the vesting period under the graded-vesting attribution method, and may be adjusted over the vesting period based on interim estimates of performance against the performance condition. During the year ended January 31, 2023, the Company recorded stock-based compensation expense for the number of PSUs considered probable of vesting based on the attainment of the performance targets. As of January 31, 2023, total unrecognized stock-based compensation cost related to PSUs was $0.6 million. This unrecognized stock-based compensation cost is expected to be recognized using the accelerated attribution method over a weighted-average period of approximately 0.8 years. Employee Stock Purchase Plan The Company’s ESPP generally provides for 24-month offering periods beginning June 15 and December 15 of each year, with each offering period consisting of four six-month purchase periods. On each purchase date, eligible employees will purchase the shares at a price per share equal to 85% of the lesser of (1) the fair market value of the Company’s stock as of the beginning of the offering period or (2) the fair market value of the Company’s stock on the purchase date, as defined in the ESPP. The following assumptions were used to calculate the fair value of shares to be granted under the ESPP during the periods: Year Ended January 31, 2023 2022 2021 Expected dividend yield — — — Expected volatility 44.1% - 65.6% 41.2% - 53.9% 39.2% - 61.6% Expected term (years) 0.5 - 2.0 0.5 - 2.0 0.5 - 2.1 Risk-free interest rate 0.11% - 4.62% 0.05% - 1.64% 0.08% - 2.39% During the fiscal years ended January 31, 2023, 2022 and 2021, the Company recognized $4.9 million, $4.7 million, and $5.3 million of stock-based compensation expense related to the ESPP, respectively, and withheld $10.0 million, $9.7 million, and $6.2 million in contributions from employees, respectively. In the fiscal year ended January 31, 2023, 495,432 shares of common stock were issued at a weighted average purchase price of $19.93. In the fiscal year ended January 31, 2022, 345,051 shares of common stock were issued at a weighted average purchase price of $22.44. In the fiscal year ended January 31, 2021, 301,842 shares of common stock were issued at a weighted average purchase price of $19.83 per share. Stock-Based Compensation Stock-based compensation expense included in the Company’s consolidated statements of operations is as follows: Year Ended January 31, 2023 2022 2021 (in thousands) Cost of revenue $ 6,827 $ 3,751 $ 1,702 Research and development 39,012 23,764 11,095 Sales and marketing (1) 29,804 19,012 14,733 General and administrative 34,264 23,506 15,701 Total $ 109,907 $ 70,033 $ 43,231 (1) Stock-based compensation expense includes a one-time stock-based compensation expense of $3.1 million related to the modification of certain stock option awards in the fiscal year ended January 31, 2021.

Net Loss per Share

Net Loss per Share	12 Months Ended
	Jan. 31, 2023
Earnings Per Share [Abstract]
Net Loss per Share	Net Loss per Share The following table presents the calculation of basic and diluted net loss per share: Year Ended January 31, 2023 2022 2021 (in thousands, except per share data) Numerator: Net loss attributable to PagerDuty, Inc. $ (128,423) $ (107,455) $ (68,903) Denominator: Weighted average shares used in calculating net loss per share, basic and diluted 88,721 84,514 79,614 Net loss per share, basic and diluted, attributable to PagerDuty, Inc. $ (1.45) $ (1.27) $ (0.87) Since the Company was in a loss position for the periods presented, basic net loss per share is the same as diluted net loss per share as the inclusion of all potential common stock outstanding would have been anti-dilutive. Potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows: As of January 31, 2023 2022 2021 (in thousands) Shares subject to outstanding common stock awards 14,989 14,522 15,149 Shares issuable pursuant to the 2019 Employee Stock Purchase Plan 106 71 73 Restricted stock issued to acquire key personnel 63 122 261 Convertible senior notes 7,173 7,173 7,173 Total 22,331 21,888 22,656

Income Taxes

Income Taxes	12 Months Ended
	Jan. 31, 2023
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The components of loss before income taxes are as follows: Year Ended January 31, 2023 2022 2021 (in thousands) Domestic $ (130,971) $ (111,426) $ (77,956) Foreign 907 4,506 5,147 Loss before provision (benefit from) for income taxes $ (130,064) $ (106,920) $ (72,809) The components of the provision (benefit from) for income taxes are as follows: Year Ended January 31, 2023 2022 2021 (in thousands) Current Federal $ — $ — $ — State — — (41) Foreign 267 181 452 Total current tax expense $ 267 $ 181 $ 411 Deferred Federal $ (794) $ — $ (4,038) State (536) — (977) Foreign 224 354 698 Total deferred tax expense (benefit) $ (1,106) $ 354 $ (4,317) Provision (benefit from) for income taxes $ (839) $ 535 $ (3,906) A reconciliation of the Company’s recorded provision for (benefit from) income taxes to the amount of taxes computed at the U.S. statutory rate is as follows: Year Ended January 31, 2023 2022 2021 (in thousands) Income taxes computed at U.S. federal statutory rate $ (27,313) $ (22,453) $ (15,291) State taxes, net of federal benefit (5,044) (8,652) (5,012) Stock-based compensation 554 (15,423) (8,443) Foreign rate differential 300 (411) 69 Tax credits, net of FIN48 reserves (1,789) (1,426) (846) Change in valuation allowance 31,350 48,364 25,076 Other 1,103 536 541 (Benefit from) provision for income taxes $ (839) $ 535 $ (3,906) The lower income tax provision in fiscal 2023 and 2021 relative to fiscal 2022 was primarily due to a reduction in the valuation allowance from the increase in the deferred tax liability associated with the acquired intangible assets from the acquisition of Catalytic and Rundeck, resulting in a $1.3 million and $5.0 million deferred tax benefit, respectively. Deferred income taxes arise from temporary differences between the carrying values of assets and liabilities for financial reporting purposes and income tax reporting purposes, as well as operating losses and tax credit carryforwards. Significant components of the Company’s deferred tax assets and liabilities are as follows: As of January 31, 2023 2022 (in thousands) Deferred tax assets: Net operating losses $ 117,735 $ 100,770 Capitalized research and development 25,568 — Allowances and accruals 10,154 8,564 Stock-based compensation 11,549 11,343 Charitable contributions 3,997 4,025 Tax credits 12,105 9,035 Lease liabilities 4,659 6,798 Other 1,519 2,475 Gross deferred tax assets $ 187,286 $ 143,010 Less: valuation allowance (162,865) (122,091) Net deferred tax assets $ 24,421 $ 20,919 Deferred tax liabilities: Deferred commissions $ (12,089) $ (11,156) Intangible assets (11,544) (6,608) Lease assets (3,497) (5,169) Other (324) (113) Gross deferred tax liabilities $ (27,454) $ (23,046) Net deferred tax liabilities $ (3,033) $ (2,127) The realization of deferred tax assets is dependent upon the generation of sufficient taxable income of the appropriate character in future periods. The Company regularly assesses the ability to realize its deferred tax assets and establishes a valuation allowance if it is more likely than not that some portion of the deferred tax assets will not be realized. The Company weighs all available positive and negative evidence, including its earnings history and results of recent operations, scheduled reversals of deferred tax liabilities, projected future taxable income, and tax planning strategies. Due to the weight of objectively verifiable negative evidence, including its history of losses in the United States and Japan, the Company believes that it is more likely than not that its U.S., federal and state, and Japan deferred tax assets will not be realized. Accordingly, the Company has recorded a full valuation allowance on such deferred tax assets. The valuation allowance against its various deferred tax assets increased by $40.8 million and $64.1 million during the fiscal years ended January 31, 2023 and 2022, respectively. As of January 31, 2023, the Company had federal net operating loss carryforwards in the amount of $451.5 million. Beginning in 2030, $70.5 million of the federal net operating losses will begin to expire. The remaining $381.0 million will carry forward indefinitely. As of January 31, 2023, the Company had state and foreign net operating loss carryforwards in the amount of $27.9 million, and $3.2 million, respectively, which begin to expire in 2028 and 2033, respectively. Utilization of the Company’s net operating loss may be subject to annual limitations due to the ownership change limitations provided by section 382 of the Internal Revenue Code and similar state provisions. The Company’s net operating loss carryforwards could expire before utilization if subject to annual limitations. As of January 31, 2023, the Company had federal, California, and Canadian research and development credit carryforwards of $11.2 million, $6.4 million, and $1.7 million, respectively. The federal research and development credits will begin to expire in 2031, the California research and development credits have no expiration, and the Canadian research and development credits will begin to expire in 2042. The following table summarizes the activity related to the Company’s unrecognized tax benefits: Year Ended January 31, 2023 2022 2021 (in thousands) Balance at beginning of period $ 6,190 $ 5,018 $ 4,043 Additions related to prior years 85 86 29 Reductions related to prior years (18) (70) (8) Additions related to current year 1,304 1,156 591 Additions related to acquired positions 162 — 363 Balance at end of period $ 7,723 $ 6,190 $ 5,018 All of the Company’s tax years remain open for examination by U.S. federal and state tax authorities. The non-U.S. tax returns remain open for examination for the years 2016 and onwards. Due to its U.S. federal and state valuation allowance, $1.0 million, $1.1 million, and $1.0 million of unrecognized tax benefits as of January 31, 2023, 2022, and 2021, respectively, would affect the effective tax rate if recognized. The Company recognizes interest and penalties related to unrecognized tax benefits as provision for income taxes. The Company has accrued an immaterial amount of interest and penalties associated with its unrecognized tax benefits noted above as of January 31, 2023. The Company does not anticipate the total amounts of unrecognized tax benefits will significantly decrease in the next 12 months. U.S. income tax has not been recognized on the excess of the amount for financial reporting over the tax basis of investments in foreign subsidiaries that is indefinitely reinvested outside the United States. As a result of current U.S. tax law, the tax impact of future distributions of foreign earnings would generally be limited to withholding tax from local jurisdictions. The amount of the deferred tax liability on the excess of the amount for financial reporting over the tax basis of investments in foreign subsidiaries is not material.

Geographic Information

Geographic Information	12 Months Ended
	Jan. 31, 2023
Segment Reporting [Abstract]
Geographic Information	Geographic Information Revenue by location is determined by the billing address of the customer. The following table sets forth revenue by geographic area: Year Ended January 31, 2023 2022 2021 (in thousands) United States $ 283,266 $ 212,829 $ 163,313 International 87,527 68,567 50,243 Total $ 370,793 $ 281,396 $ 213,556

Restructuring Costs

Restructuring Costs	12 Months Ended
	Jan. 31, 2023
Restructuring and Related Activities [Abstract]
Restructuring Costs	Restructuring CostsOn January 24, 2023, as part of the Company’s ongoing actions to drive efficient growth and expand operating margins, the Company announced that it will implement changes including reallocating certain roles and realigning teams to continue to improve operational resiliency and agility. The immediate impact is a 7% reduction in headcount, as some roles are eliminated and new roles created in high-talent, lower-cost geographies. During the fiscal year ended January 31, 2023, the Company incurred costs associated with the restructuring plan of approximately $5.0 million which is primarily comprised of severance payments, employee benefit contributions and other related costs. In connection with this action, the Company recorded the restructuring costs within the cost of sales, research and development, sales and marketing, and general and administrative operating expense line items of its consolidated statements of operations as of January 31, 2023. The majority of the amounts accrued are expected to be paid in the three months ended April 30, 2023.

401(k) Plan

401(k) Plan	12 Months Ended
	Jan. 31, 2023
Retirement Benefits [Abstract]
401(k) Plan	401(k) PlanThe Company has a qualified defined contribution plan under Section 401(k) of the Internal Revenue Code covering eligible employees. The 401(k) plan allows each participant to contribute up to an amount not to exceed an annual statutory maximum. The Company is responsible for the administrative costs of the 401(k) plan, and effective July 1, 2019, the Company implemented an employer matching contribution. Effective January 1, 2022, the employer matching contribution was increased from one percent (1%) of each participant’s employee contributions of at least 1% of eligible wages during the period to two percent (2%) of each participant’s employee contributions of at least 2% of eligible wages during the period. During the fiscal years ended January 31, 2023, 2022, and 2021, the Company recognized expense of $2.6 million, $1.3 million, and $0.8 million, respectively, related to matching contributions.

Subsequent Events

Subsequent Events	12 Months Ended
	Jan. 31, 2023
Subsequent Events [Abstract]
Subsequent Events	Subsequent EventsThe Company has evaluated subsequent events through March 16, 2023.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Jan. 31, 2023
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and include the results of the Company, its wholly owned subsidiaries, and subsidiaries in which the Company holds a controlling interest. All intercompany balances and transactions have been eliminated upon consolidation. The Company’s fiscal year ends on January 31. References to fiscal 2023, for example, refer to the fiscal year ended January 31, 2023.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make, on an ongoing basis, estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates. The Company’s most significant estimates and judgments involve the period of benefit for amortizing deferred contract costs, the determination of the allowance for credit losses, fair value of acquired assets and assumed liabilities, and estimates related to the Company’s revenue recognition, such as the assessment of performance obligations in the Company’s revenue arrangements and the fair value assigned to each performance obligation, among others. Management bases its estimates on historical experience and on various other assumptions which management believes to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.
Segment Information	Segment Information The Company manages its operations and allocates resources as one operating segment. The Company’s chief operating decision maker (“CODM”) is its chief executive officer, who reviews financial information presented on a consolidated basis for purposes of making operating decisions, assessing financial performance, and allocating resources.
Revenue Recognition, Deferred Revenue, Deferred Contract Costs, and Cost of Revenue	Revenue Recognition The Company generates revenue primarily from cloud-hosted subscription fees with the majority of its revenue from such arrangements. The Company also generates revenue from term-license software subscription fees. Revenue is recognized when control of these services is transferred to its customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services. The Company accounts for revenue contracts with customers by applying the requirements of Topic 606, which includes the following steps: • Identification of the contract, or contracts, with a customer. • Identification of the performance obligations in the contract. • Determination of the transaction price. • Allocation of the transaction price to the performance obligations in the contract. • Recognition of revenue when, or as, the Company satisfies a performance obligation. Cloud-hosted software subscriptions The Company’s cloud-hosted software subscriptions allow customers to use its cloud-hosted software over the contract period without taking possession of the software. The Company’s cloud-hosted software subscription agreements generally have monthly or annual contractual terms. Revenue related to the Company’s cloud-hosted software subscriptions is recognized ratably over the related contractual term beginning on the date that the Company’s platform is made available to a customer. Access to the platform represents a series of distinct services as the Company continually provides access to, and fulfills its obligation to, the end customer over the subscription term. The series of distinct services represents a single performance obligation that is satisfied over time. The Company recognizes revenue ratably because the customer receives and consumes the benefits of the platform throughout the contract period. Term-license software subscriptions The Company’s term license software subscriptions provide both an obligation to provide access to its on-premise software, which includes both open source and proprietary features, as well as an obligation to provide support and maintenance. The Company’s term-license software subscription agreements generally have annual contractual terms. The Company accounts for the license to the software and support as two separate performance obligations. As the open source software is publicly available at no cost to the customer, the Company has determined that there is no value to be assigned to the open source software in the term-license software subscription arrangements. The proprietary software license represents a promise to provide a license to use functional intellectual property that is recognized at a point in time on the date access to the software is made available to the customer and the term-license software subscription period has begun. The Company has concluded the support is a stand-ready performance obligation that consists of a series of distinct services that are satisfied ratably over time as the services are provided. The Company uses a time-based output method to measure progress because efforts are expended evenly throughout the period given the nature of the promise is a stand-ready service. The Company recognizes support revenue ratably, typically beginning on the start of the contractual term of the arrangement. Cloud-hosted and term license software subscriptions In order to determine the stand-alone selling price, the Company conducts a periodic analysis that requires judgment and considers multiple factors that are reasonably available and maximizes the use of observable inputs that may vary over time depending upon the unique facts and circumstances related to each performance obligation. To have observable inputs, the Company requires that a substantial majority of the stand-alone selling prices for a product offering fall within a pricing range. If a directly observable stand-alone selling price does not exist, the Company estimates a stand-alone selling price range by reviewing external and internal market factor categories, which may include pricing practices, historical discounting, industry practices, service groups, and geographic considerations. The Company believes that these analyses result in an estimate that approximates the price the Company would charge for the performance obligations if they were sold separately. The Company’s cloud-hosted and term-license software subscription arrangements are generally non-cancellable and do not contain refund provisions. The Company bills for monthly cloud-hosted and term-license software subscriptions on a monthly basis and annually in advance for arrangements with terms of one year or more. Deferred Revenue The Company records contract liabilities to deferred revenue when amounts are invoiced in advance of performance. Deferred revenue consists of the unearned portion of customer billings. The Company’s payment terms generally provide for payment within 30 days of the invoice date. Amounts anticipated to be recognized within one year of the balance sheet date are recorded as deferred revenue, current; the remaining portion is recorded as deferred revenue, non-current in the consolidated balance sheets. The Company applied the practical expedient in Topic 606 and did not evaluate contracts of one year or less for the existence of a significant financing component. For contracts with terms of more than a year, the Company has determined its contracts generally do not include a significant financing component as the majority relate to contracts that are billed annually in advance. The primary purpose of the Company’s invoicing terms is to provide customers with simplified and predictable ways of purchasing the Company’s cloud- hosted software subscription, not to receive financing from its customers or to provide customers with financing. Deferred Contract Costs Deferred contract costs consist of sales commissions earned by the Company’s sales force which are considered incremental and recoverable costs of obtaining a contract with a customer. The Company determined that sales commissions that are related to contract renewals are not commensurate with commissions earned on the initial contract. Accordingly, sales commissions for initial contracts are deferred and then amortized on a straight-line basis over a period of benefit that the Company has determined to be four years. The Company determined the period of benefit by taking into consideration its customer contracts, technology, and other factors. Amounts anticipated to be recognized within one year of the balance sheet date are recorded as deferred contract costs, current; the remaining portion is recorded as deferred contract costs, noncurrent in the consolidated balance sheets. Deferred contract costs are periodically reviewed for impairment. Amortization of deferred contract costs is included in sales and marketing expense in the consolidated statements of operations.
Accounts Receivable and Related Allowance	Accounts Receivable and Related Allowance for Credit LossesAccounts receivable are recorded at the invoiced amount, net of allowances for credit losses. The allowance is based upon historical loss patterns, customer credit quality, the age of each past due invoice, and an evaluation of the potential risk of loss associated with delinquent accounts. The allowance also reflects current market conditions and reasonable and supportable forecasts of future economic conditions.
Concentrations of Risk and Significant Customers	Concentrations of Risk and Significant CustomersThe Company’s financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents, available-for-sale investments, and accounts receivable. All of the Company’s cash equivalents and investments are invested in money market funds, United States (“U.S.”) Treasury securities, commercial paper, corporate debt securities, or U.S. Government agency securities that management believes to be of high credit quality. The Company’s cash, cash equivalents, and available-for-sale investments are spread across several different financial institutions.
Foreign Currency Remeasurement	Foreign Currency Translation The functional currency for the large majority of the Company's foreign operations is the U.S. dollar, although the Company has one subsidiary use the local currency as its functional currency for the fiscal year ended January 31, 2023. When a consolidated entity’s functional currency is the local currency, the Company translates the foreign functional currency financial statements to U.S. dollars using the exchange rates at the balance sheet date for assets and liabilities, the period average exchange rates for revenue and expenses, and the historical exchange rates for equity. The effects of foreign currency translation adjustments are recorded in other comprehensive income as a component of stockholders’ equity and the related periodic movements are presented in the consolidated statements of comprehensive loss. Foreign currency transaction gains and losses are included in other income (expense), net, in the consolidated statements of operations for the period. Realized foreign currency transaction gains and losses for the fiscal years ended January 31, 2023, 2022, and 2021 were not material.
Cash and Cash Equivalents	Cash and Cash EquivalentsCash and cash equivalents consist of cash on hand, highly liquid investments with original maturities of three months or less from the date of purchase, and money market funds.
Investments	Investments The Company’s investments are classified as available-for-sale and consist of highly liquid investments, primarily commercial paper, corporate debt securities, U.S. Government agency securities, and U.S. Treasury securities. The Company determines the appropriate classification of its investments at the time of purchase and reevaluates such designation at each balance sheet date. The Company periodically evaluates its short-term investments to assess whether those with unrealized loss positions are impaired. The Company considers various factors in determining whether to recognize an impairment charge, including the extent to which the fair value is less than the Company’s cost basis, the financial condition of the issuer and any changes thereto, and the Company’s intent to sell, or whether it is more likely than not that the Company will be required to sell, the investment before recovery of the investment’s amortized cost. If the Company determines that the investment is impaired, an impairment loss is recognized in earnings equal to the difference between the investment’s amortized cost and fair value at such date. Realized gains and losses are reported in other income, net, in the consolidated statements of operations. No impairment charges have been recognized to date. Available-for-sale
Property and Equipment, Net	Property and Equipment, Net Property and equipment, net, are stated at cost less accumulated depreciation. Depreciation is recorded using the straight-line method over the estimated useful lives of the respective assets, which is generally three
Research and Development Expense	Research and Development Expense Research and development expenses consist primarily of personnel costs for the Company’s engineering, product, and design teams. Additionally, research and development expenses include contractor fees, depreciation of
Internal-Use Software Costs	Internal-Use Software CostsThe Company evaluates costs related to the development of its platform and certain projects for internal use incurred during the application development stage. Costs related to preliminary project activities and post-implementation activities are expensed as incurred and costs related to the application development stage are capitalized. Internal-use software is amortized on a straight-line basis over its estimated useful life, which is generally three years. Management evaluates the useful lives of these assets on an annual basis and tests for impairment whenever events or changes in circumstances occur that could impact the recoverability of these assets.
Business Combinations	Business CombinationsThe Company applies the acquisition method of accounting for business combinations. Under this method of accounting, all assets acquired and liabilities assumed are recorded at their respective fair values at the date of the acquisition. Determining the fair value of assets acquired and liabilities assumed requires management’s judgment and often involves the use of significant estimates and assumptions. These estimates can include, but are not limited to, the cash flows that an asset is expected to generate in the future, the appropriate weighted-average cost of capital, and the cost savings expected to be derived from acquiring an asset.
Goodwill and Acquired Intangible Assets	Goodwill. Goodwill represents the excess purchase consideration of an acquired business over the fair value of the net tangible and identifiable intangible assets. Goodwill is evaluated for impairment annually in the fourth quarter, and whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable. Triggering events that may indicate impairment include, but are not limited to, a significant adverse change in customer demand or business climate or a significant decrease in expected cash flows. No impairment charges were recorded during the fiscal years ended January 31, 2023, 2022, or 2021. Acquired Intangible Assets. Acquired intangible assets consist of identifiable intangible assets, primarily developed technology and customer relationships, resulting from the Company’s business acquisition. Intangible assets are recorded at fair value on the date of acquisition and amortized over their estimated useful lives.
Impairment of Long-Lived Assets	Impairment of Long-Lived Assets. The carrying amounts of the Company’s long-lived assets, including property and equipment, lease right-of-use assets, capitalized internal-use software, and acquired intangible assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying value of these assets may not be recoverable or that the useful lives are shorter than originally estimated. Recoverability of these assets is measured by a comparison of the carrying amounts to the future undiscounted cash flows the assets are expected to generate. If long-lived assets are considered impaired, the impairment to be recognized equals the amount by which the carrying value of the asset exceeds its fair value. If the Company reduces the estimated useful life assumption for any asset, the remaining unamortized balance would be amortized or depreciated over the revised estimated useful life.
Advertising Costs	Advertising CostsAdvertising costs are expensed as incurred and are included in sales and marketing expense.
Stock-Based Compensation	Stock-Based Compensation The Company recognizes compensation expense for all stock-based payment awards, including stock options, restricted stock units (“RSUs”) and performance stock units (“PSUs”), based on the estimated fair value of the award on the grant date. The Company estimates the fair value of stock options issued to employees on the date of grant using the Black-Scholes option pricing model, which is impacted by the estimated fair value of the Company’s common stock, as well as certain assumptions including the expected volatility over the term of the option awards, the expected term of the awards, risk-free interest rates and the expected dividend yield. Assumptions and estimates used in the determination of the fair value of stock options include expected volatility, expected term, risk-free rate, and expected dividend yield. The Company estimates the fair value of RSUs and PSUs at its stock price on the grant date. The Company estimates the fair value of shares to be issued under the employee stock purchase plan (the “ESPP”) on the first day of the offering period using the Black-Scholes valuation model, which is impacted by the estimated fair value of the Company’s common stock, as well as certain assumptions including the expected volatility over the term of the offering period, the expected term of the awards, risk-free interest rates and the expected dividend yield. Assumptions used in the determination of the fair value of the ESPP are the same as those used in the determination of the fair value of the Company’s stock options. The Company generally recognizes compensation expense for employee stock-based payment awards on a straight-line basis over the period during which an award recipient is required to provide services in exchange for the award (generally the vesting period of the award), with the exception of PSUs which are recognized using the accelerated attribution method. The Company accounts for forfeitures as they occur. The fair value of each non-employee stock option is estimated at the date of grant using the Black-Scholes option pricing model and is not remeasured over the vesting term. Assumptions used in valuing non-employee stock options are generally consistent with those used for employee stock options with the exception that the expected term is over the contractual life.
Income Taxes	Income Taxes The Company accounts for income taxes using the asset and liability method. Under this method, the Company recognizes deferred income tax assets and liabilities for the expected future consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, as well as for net operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using the tax rates that are expected to apply to taxable income for the years in which those tax assets and liabilities are expected to be realized or settled. The Company recognizes the deferred income tax effects of a change in tax rates in the period of enactment. The Company records a valuation allowance to reduce its deferred tax assets to the net amount that it believes is more likely than not to be realized. The Company considers all available evidence, both positive and negative, including historical levels of income, expectations and risks associated with estimates of future taxable income and ongoing tax planning strategies in assessing the need for a valuation allowance. Realization of its deferred tax assets is dependent primarily upon future U.S. taxable income. The Company recognizes income tax benefits from uncertain tax positions only if it believes that it is more likely than not that the tax position will be sustained upon examination by the taxing authorities based on the technical merits of the position. The tax benefits recognized in the financial statements from such uncertain tax positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized upon settlement. Although the Company believes that it has adequately reserved for its uncertain tax positions (including net interest and penalties), it can provide no assurance that the final tax outcome of these matters will not be materially different. The Company makes adjustments to these reserves when facts and circumstances change, such as the closing of a tax audit or the refinement of an estimate. To the extent that the final tax outcome of these matters is different from the amounts recorded, such differences will affect the provision for income taxes in the period in which such determination is made and could have a material impact on its financial position, results of operations, and cash flows.
Net Loss Per Common Share	Net Loss Per ShareBasic net loss per share is computed by dividing net loss by the weighted-average number of shares of common stock outstanding during the period. Diluted net loss per share is computed by dividing net loss by the weighted-average number of shares of common stock outstanding during the period giving effect to all potentially dilutive securities to the extent they are dilutive. The dilutive effect of potentially dilutive securities is reflected in diluted net loss per share by application of the treasury stock method. Basic and diluted net loss per share of common stock were the same for each period presented as the inclusion of all potential shares of common stock outstanding would have been anti-dilutive.
Recently Issued/Adopted Accounting Pronouncements	Recently Adopted Accounting Pronouncements In October 2021, the FASB issued Accounting Standard Update No. 2021-08 (“ASU 2021-08”), Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers , which requires that an entity (acquirer) recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606 (Revenue from Contracts with Customers). At the acquisition date, an acquirer should account for the related revenue contracts in accordance with Topic 606 as if it had originated the contracts. The ASU is part of the FASB's simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. The Company early adopted ASU 2022-08 as of February 1, 2022 using the prospective method. The adoption of the standard impacted the accounting for the acquisition of Catalytic, Inc. (“Catalytic”) requiring the Company to measure acquired contract assets and liabilities in accordance with ASC 606. The adoption of ASU 2021-08 did not have a material impact on the consolidated financial statements.
Fair Value Measurements	The Company measures its financial assets and liabilities at fair value each reporting period using a fair value hierarchy that prioritizes the use of observable inputs and minimizes the use of unobservable inputs when measuring fair value. A financial instrument’s classification within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Three levels of inputs may be used to measure fair value, as follows: Level 1—Valuations based on observable inputs that reflect quoted prices for identical assets or liabilities in active markets. Level 2—Valuations based on inputs that are directly or indirectly observable in the marketplace. Level 3—Valuations based on unobservable inputs that are supported by little or no market activity.
Operating Leases	Operating Leases The Company has entered into various non-cancellable operating leases for its office spaces with lease periods expiring between fiscal 2023 and fiscal 2029. The operating lease agreements generally provide for rental payments on a graduated basis and for options to renew, which could increase future minimum lease payments if exercised. Lease right-of-use assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As the leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. The lease right-of-use assets also include any lease payments made and exclude lease incentives such as tenant improvement allowances. The operating leases typically include non-lease components such as common-area maintenance costs. The Company has elected to include non-lease components with lease payments for the purpose of calculating lease right-of-use assets and liabilities, to the extent that they are fixed. Non-lease components that are not fixed are expensed as incurred as variable lease payments.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Jan. 31, 2023
Accounting Policies [Abstract]
Activity Related to Allowance for Doubtful Accounts	Activity related to the Company’s allowance for credit losses on accounts receivable was as follows: Amount (in thousands) Balance as of January 31, 2021 $ 1,188 Charged to bad debt expense 1,099 Write-offs, net of recoveries (478) Balance as of January 31, 2022 $ 1,809 Charged to bad debt expense 1,063 Write-offs, net of recoveries (858) Balance as of January 31, 2023 $ 2,014
Rollforward of Deferred Contract Costs	The following table represents a rollforward of the Company’s deferred contract costs: Amount (in thousands) Balance as of January 31, 2021 $ 31,587 Additions to deferred contract costs 26,167 Amortization of deferred contract costs (14,923) Balance as of January 31, 2022 $ 42,831 Additions to deferred contract costs 22,805 Amortization of deferred contract costs (19,247) Balance as of January 31, 2023 $ 46,389

Redeemable Non-Controlling In_2

Redeemable Non-Controlling Interest (Tables)	12 Months Ended
	Jan. 31, 2023
Noncontrolling Interest [Abstract]
Redeemable Noncontrolling Interest	The following table summarizes the activity in the redeemable non-controlling interest for the period indicated below: January 31, 2023 (in thousands) Balance at beginning of period $ — Investment by redeemable non-controlling interest 1,908 Net loss attributable to redeemable non-controlling interest (802) Foreign currency translation adjustments 2 Balance at end of period $ 1,108

Balance Sheet Components (Table

Balance Sheet Components (Tables)	12 Months Ended
	Jan. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Components of Cash and Cash Equivalents	Cash, cash equivalents, and investments consisted of the following: As of January 31, 2023 2022 (in thousands) Cash and cash equivalents Cash $ 67,151 $ 268,091 Money market funds 206,868 73,194 Commercial paper — 5,500 U.S. Treasury securities — 3,000 Total cash and cash equivalents $ 274,019 $ 349,785 Available-for-sale investments U.S. Treasury securities $ 51,387 $ 41,105 Commercial paper 34,798 39,483 Corporate debt securities 108,827 112,983 U.S. Government agency securities 7,936 — Total available-for-sale investments $ 202,948 $ 193,571
Components of Available-for-sale Investments	Cash, cash equivalents, and investments consisted of the following: As of January 31, 2023 2022 (in thousands) Cash and cash equivalents Cash $ 67,151 $ 268,091 Money market funds 206,868 73,194 Commercial paper — 5,500 U.S. Treasury securities — 3,000 Total cash and cash equivalents $ 274,019 $ 349,785 Available-for-sale investments U.S. Treasury securities $ 51,387 $ 41,105 Commercial paper 34,798 39,483 Corporate debt securities 108,827 112,983 U.S. Government agency securities 7,936 — Total available-for-sale investments $ 202,948 $ 193,571
Summary of Carrying Value of Available-for-sale Investments	The following tables summarize the Company’s investments’ adjusted cost, net unrealized (losses) gains, and fair value by significant investment category as of January 31, 2023 and 2022. Gross realized gains or losses from sales of available-for-sale securities were not material for the fiscal years ended January 31, 2023 and 2022. As of January 31, 2023 Cost Basis Unrealized Loss, Net Recorded Basis (in thousands) Available-for-sale investments U.S. Treasury securities $ 51,400 $ (13) $ 51,387 Commercial paper 34,926 (128) 34,798 Corporate debt securities 110,063 (1,236) 108,827 U.S. Government agency securities 8,000 (64) 7,936 Total investments $ 204,389 $ (1,441) $ 202,948 As of January 31, 2022 Cost Basis Unrealized Loss, Net Recorded Basis (in thousands) Available-for-sale investments U.S. Treasury securities $ 41,147 $ (42) $ 41,105 Commercial paper 39,528 (45) 39,483 Corporate debt securities 113,565 (582) 112,983 Total investments $ 194,240 $ (669) $ 193,571
Summary of Contractual Maturities of Available-for-sale Securities	The following tables present the Company’s available-for-sale securities by contractual maturity date as of January 31, 2023 and 2022: As of January 31, 2023 Adjusted Cost Fair Value (in thousands) Due within one year $ 139,443 $ 138,625 Due between one to five years 64,946 64,323 $ 204,389 $ 202,948 January 31, 2022 Adjusted Cost Fair Value (in thousands) Due within one year $ 154,692 $ 154,455 Due between one to five years 39,548 39,116 $ 194,240 $ 193,571
Components of Property and Equipment, Net	Property and equipment, net consisted of the following: As of January 31, 2023 2022 (in thousands) Leasehold improvements $ 15,585 $ 15,392 Computers and equipment 9,426 7,483 Furniture and fixtures 4,730 4,686 Capitalized internal-use software 10,971 6,136 Gross property and equipment (1) $ 40,712 $ 33,697 Accumulated depreciation and amortization (22,322) (15,468) Property and equipment, net $ 18,390 $ 18,229 (1) Gross property and equipment includes construction-in-progress for leasehold improvements and capitalized internal-use software of $6.0 million and $6.9 million that had not yet been placed in service as of January 31, 2023 and January 31, 2022, respectively. The costs associated with construction-in-progress are not amortized until placed in service.
Schedule of Accrued Expenses, Other Current Liabilities, and Accrued Compensation	Accrued expenses and other current liabilities consisted of the following: As of January 31, 2023 2022 (in thousands) Accrued professional fees $ 4,926 $ 3,790 Accrued events 952 463 Accrued hosting and infrastructure 1,384 1,495 Accrued taxes 1,711 1,056 Accrued liabilities, other 2,831 6,836 Accrued expenses and other liabilities $ 11,804 $ 13,640 Accrued compensation consisted of the following: As of January 31, 2023 2022 (in thousands) Accrued bonuses $ 15,594 $ 13,480 Accrued compensation, other 26,240 21,847 Accrued compensation $ 41,834 $ 35,327

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	12 Months Ended
	Jan. 31, 2023
Fair Value Disclosures [Abstract]
Summary of Information about Company's Financial Assets	The following tables present information about the Company’s financial assets that are required to be measured or disclosed at fair value using the above input categories: As of January 31, 2023 Level 1 Level 2 Level 3 Total (in thousands) Money market funds $ 206,868 $ — $ — $ 206,868 U.S. Treasury securities — 51,387 — 51,387 Commercial paper — 34,798 — 34,798 Corporate debt securities — 108,827 — 108,827 U.S. Government agency securities — 7,936 — 7,936 Total $ 206,868 $ 202,948 $ — $ 409,816 Included in cash equivalents $ 206,868 Included in investments $ 202,948 As of January 31, 2022 Level 1 Level 2 Level 3 Total (in thousands) Money market funds $ 73,194 $ — $ — $ 73,194 U.S. Treasury securities 3,000 41,105 — 44,105 Commercial paper 5,500 39,483 — 44,983 Corporate debt securities — 112,983 — 112,983 Total $ 81,694 $ 193,571 $ — $ 275,265 Included in cash equivalents $ 81,694 Included in investments $ 193,571

Business Combinations (Tables)

Business Combinations (Tables)	12 Months Ended
	Jan. 31, 2023
Business Combinations [Abstract]
Schedule of Allocation of Purchase Consideration	The following table presents the fair values of acquired assets and liabilities recorded in the Company’s consolidated balance sheet as of the acquisition date: (in thousands) Cash and cash equivalents $ 2,506 Accounts receivable and other assets 801 Prepaid and other current assets 841 Intangible assets 21,800 Goodwill 46,736 Accounts payable and other liabilities (408) Deferred revenue (856) Other tax liabilities (1,322) Deferred tax liability (1,330) Total purchase consideration $ 68,768
Schedule of Components of Identifiable Intangible Assets Acquired	The following table sets forth the components of identifiable intangible assets acquired and their estimated useful lives as of the date of acquisition: Fair Value Useful Life (in thousands) (in years) Developed technology $ 19,200 3 Customer relationships $ 2,600 10

Goodwill and Acquired Intangi_2

Goodwill and Acquired Intangible Assets (Tables)	12 Months Ended
	Jan. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Changes in Goodwill	The changes in the carrying amount of goodwill for the fiscal years ended January 31, 2023 and 2022 are as follows: Goodwill (in thousands) Balance as of January 31, 2021 $ 72,126 Goodwill resulting from business combination — Balance as of January 31, 2022 $ 72,126 Goodwill resulting from business combination 46,736 Balance as of January 31, 2023 $ 118,862
Schedule of Intangible Assets Subject to Amortization	Intangible assets subject to amortization consist of the following: As of January 31, 2023 Cost Accumulated Amortization Net Weighted Average (in thousands) (in years) Customer relationships $ 24,400 $ (5,319) $ 19,081 7.9 Developed technology 24,800 (8,342) 16,458 2.3 Trademarks 400 (400) — 0.0 Assembled workforce 2,527 (842) 1,685 1.3 Other intangibles, net $ 52,127 $ (14,903) $ 37,224 As of January 31, 2022 Cost Accumulated Amortization Net Weighted Average (in thousands) (in years) Customer relationships $ 21,800 $ (2,907) $ 18,893 8.7 Developed technology 5,600 (1,493) 4,107 3.7 Trademarks 400 (267) 133 0.7 Other intangibles, net $ 27,800 $ (4,667) $ 23,133
Schedule of Expected Amortization Expense in Future Periods	As of January 31, 2023, expected amortization expense in future periods is as follows: Year ending January 31, (in thousands) 2024 $ 11,224 2025 10,381 2026 3,858 2027 2,440 2028 2,440 Thereafter 6,881 Total expected future amortization expense $ 37,224

Leases (Tables)

Leases (Tables)	12 Months Ended
	Jan. 31, 2023
Leases [Abstract]
Information About Lease on Condensed Consolidated Balance Sheet	The following tables present information about leases on the consolidated balance sheet. As of January 31, 2023 2022 (in thousands) Assets Lease right-of-use assets $ 13,982 $ 20,227 Liabilities Lease liabilities 5,904 5,637 Lease liabilities, non-current 12,704 20,912
Information About Leases on Condensed Consolidated Statement of Operations and Supplemental Cash Flow Information	The following table presents information about leases on the consolidated statement of operations. Year Ended January 31, 2023 2022 2021 (in thousands) Operating lease expense $ 5,651 $ 5,574 $ 5,769 Short-term lease expense 1,842 756 879 Variable lease expense 1,363 939 1,325 The following table presents supplemental cash flow information about the Company’s leases. Year Ended January 31, 2023 2022 2021 (in thousands) Cash paid for amounts included in the measurement of lease liabilities $ 7,025 $ 6,319 $ 5,416
Schedule of Remaining Maturities of Lease Liabilities	As of January 31, 2023, remaining maturities of lease liabilities are as follows: Year ending January 31, (in thousands) 2024 $ 6,482 2025 6,402 2026 2,244 2027 1,910 2028 1,967 Thereafter 1,011 Gross lease payments $ 20,016 Less: Imputed interest (1,408) Total $ 18,608

Debt and Financing Arrangemen_2

Debt and Financing Arrangements (Tables)	12 Months Ended
	Jan. 31, 2023
Debt Disclosure [Abstract]
Net Carrying Amount of Liability and Equity Components of Convertible Notes	The net carrying amount of the liability component of the Notes as of January 31, 2023 and 2022 is as follows: As of January 31, 2023 2022 (in thousands) Principal $ 287,500 $ 287,500 Less: unamortized issuance costs (4,592) (6,431) Net carrying amount $ 282,908 $ 281,069 Interest expense recognized related to the Notes during the year ended January 31, 2023, 2022, and 2021 is as follows: Year Ended January 31, 2023 2022 2021 (in thousands) Contractual interest expense $ 3,594 $ 3,594 $ 2,157 Amortization of debt discount — — 7,104 Amortization of debt issuance costs 1,839 1,804 704 Total interest expense related to the Notes $ 5,433 $ 5,398 $ 9,965

Commitment and Contingencies (T

Commitment and Contingencies (Tables)	12 Months Ended
	Jan. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Contractual Obligation, Fiscal Year Maturity	As of January 31, 2023, the Company’s contractual obligations are as follows for the years ending January 31: Operating Lease Obligations (1) Purchase Commitments (2) Senior Convertible Notes (3) Total Year ending January 31, (in thousands) 2024 $ 6,482 $ 38,065 $ 3,594 $ 48,141 2025 6,402 21,846 3,594 31,842 2026 2,244 1,346 289,297 292,887 2027 1,910 — — 1,910 2028 1,967 — — 1,967 Thereafter 1,011 — — 1,011 Total $ 20,016 $ 61,257 $ 296,485 $ 377,758 (1) Represents obligations under non-cancellable lease agreements for the Company’s corporate headquarters and worldwide offices. (2) Primarily relates to contractual third-party services. (3) Includes principal and interest payments. For more information regarding the Company’s convertible senior notes, refer to Note 9 , “Debt and Financing Arrangements” .

Deferred Revenue and Performa_2

Deferred Revenue and Performance Obligations (Tables)	12 Months Ended
	Jan. 31, 2023
Revenue from Contract with Customer [Abstract]
Summary of Deferred Revenue	The following table presents the changes to the Company’s deferred revenue: Year Ended January 31, 2023 2022 2021 (in thousands) Deferred revenue, beginning of period $ 170,224 $ 129,972 $ 92,569 Billings 408,764 321,648 248,279 Deferred revenue assumed in business combinations 856 — 2,680 Revenue recognized (370,793) (281,396) (213,556) Deferred revenue, end of period $ 209,051 $ 170,224 $ 129,972

Common Stock and Stockholders_2

Common Stock and Stockholders' Equity (Tables)	12 Months Ended
	Jan. 31, 2023
Equity [Abstract]
Summary of Shares of Common Stock Reserved for Future Issuance	Shares of common stock reserved for future issuance are as follows: January 31, 2023 Outstanding stock options and unvested RSUs and PSUs 15,752,820 Available for future stock option, RSU, and PSU grants 13,581,239 Available for ESPP 2,971,223 Total common stock reserved at January 31, 2023 32,305,282
Schedule of Stock Option Activity	Stock option activity is as follows: Number of Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term Aggregate Intrinsic Value (in thousands) Outstanding at January 31, 2022 8,375,866 $ 9.28 6.1 $ 198,828 Granted 24,882 $ 34.22 Exercised (2,093,704) $ 5.21 Canceled (156,063) $ 15.56 Outstanding at January 31, 2023 6,150,981 $ 10.61 5.3 $ 117,986 Vested as of January 31, 2023 5,538,328 $ 9.23 5.1 $ 113,852
Schedule of Assumptions Used to Calculate Fair Value of Employee Stock Option Grants Made	The following assumptions were used to calculate the fair value of employee stock option grants made during the periods: Year Ended January 31, 2023 2022 2021 Expected dividend yield — — — Expected volatility 47.1% 43.8% - 46.9% 43.0% - 44.1% Expected term (years) 6.1 6.1 3.7 - 6.1 Risk-free interest rate 2.50% 1.04% - 1.35% 0.20% - 0.52%
Schedule of Restricted Stock Unit Activity	A summary of the Company’s RSU activity and related information is as follows: Number of RSUs Weighted Average Grant Date Fair Value Per Share Outstanding at January 31, 2022 6,028,201 $ 34.77 Granted 6,022,637 $ 30.81 Vested (1,721,589) $ 33.25 Forfeited or canceled (2,316,767) $ 33.26 Outstanding at January 31, 2023 8,012,482 $ 32.55
Schedule of Assumptions Used to Calculate Fair Value of Shares to be Granted Under the ESPP	The following assumptions were used to calculate the fair value of shares to be granted under the ESPP during the periods: Year Ended January 31, 2023 2022 2021 Expected dividend yield — — — Expected volatility 44.1% - 65.6% 41.2% - 53.9% 39.2% - 61.6% Expected term (years) 0.5 - 2.0 0.5 - 2.0 0.5 - 2.1 Risk-free interest rate 0.11% - 4.62% 0.05% - 1.64% 0.08% - 2.39%
Schedule of Stock-based Compensation Expense	Stock-based compensation expense included in the Company’s consolidated statements of operations is as follows: Year Ended January 31, 2023 2022 2021 (in thousands) Cost of revenue $ 6,827 $ 3,751 $ 1,702 Research and development 39,012 23,764 11,095 Sales and marketing (1) 29,804 19,012 14,733 General and administrative 34,264 23,506 15,701 Total $ 109,907 $ 70,033 $ 43,231 (1) Stock-based compensation expense includes a one-time stock-based compensation expense of $3.1 million related to the modification of certain stock option awards in the fiscal year ended January 31, 2021.
Share-based Payment Arrangement, Performance Shares, Activity	A summary of the Company’s PSU activity and related information is as follows: Number of PSUs Weighted Average Grant Date Fair Value Per Share Outstanding at January 31, 2022 117,701 $ 41.17 Granted (1) 767,409 $ 32.64 Vested (47,416) $ 41.17 Forfeited or canceled (46,968) $ 40.71 Performance adjustment for 2021 PSU Awards 34,332 $ 41.17 Outstanding at January 31, 2023 825,058 $ 33.27 (1) This amount represents awards granted at 100% attainment.

Net Loss per Share (Tables)

Net Loss per Share (Tables)	12 Months Ended
	Jan. 31, 2023
Earnings Per Share [Abstract]
Calculation of Basic and Diluted Net Loss Per Share	The following table presents the calculation of basic and diluted net loss per share: Year Ended January 31, 2023 2022 2021 (in thousands, except per share data) Numerator: Net loss attributable to PagerDuty, Inc. $ (128,423) $ (107,455) $ (68,903) Denominator: Weighted average shares used in calculating net loss per share, basic and diluted 88,721 84,514 79,614 Net loss per share, basic and diluted, attributable to PagerDuty, Inc. $ (1.45) $ (1.27) $ (0.87)
Schedule of Anti-dilutive Securities That Were Not Included in Diluted Per Share Calculations	Potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows: As of January 31, 2023 2022 2021 (in thousands) Shares subject to outstanding common stock awards 14,989 14,522 15,149 Shares issuable pursuant to the 2019 Employee Stock Purchase Plan 106 71 73 Restricted stock issued to acquire key personnel 63 122 261 Convertible senior notes 7,173 7,173 7,173 Total 22,331 21,888 22,656

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Jan. 31, 2023
Income Tax Disclosure [Abstract]
Components of Income (Loss) Before Income Taxes	The components of loss before income taxes are as follows: Year Ended January 31, 2023 2022 2021 (in thousands) Domestic $ (130,971) $ (111,426) $ (77,956) Foreign 907 4,506 5,147 Loss before provision (benefit from) for income taxes $ (130,064) $ (106,920) $ (72,809)
Components of Provision for Income Taxes	The components of the provision (benefit from) for income taxes are as follows: Year Ended January 31, 2023 2022 2021 (in thousands) Current Federal $ — $ — $ — State — — (41) Foreign 267 181 452 Total current tax expense $ 267 $ 181 $ 411 Deferred Federal $ (794) $ — $ (4,038) State (536) — (977) Foreign 224 354 698 Total deferred tax expense (benefit) $ (1,106) $ 354 $ (4,317) Provision (benefit from) for income taxes $ (839) $ 535 $ (3,906)
Reconciliation of Provision for Income Taxes	A reconciliation of the Company’s recorded provision for (benefit from) income taxes to the amount of taxes computed at the U.S. statutory rate is as follows: Year Ended January 31, 2023 2022 2021 (in thousands) Income taxes computed at U.S. federal statutory rate $ (27,313) $ (22,453) $ (15,291) State taxes, net of federal benefit (5,044) (8,652) (5,012) Stock-based compensation 554 (15,423) (8,443) Foreign rate differential 300 (411) 69 Tax credits, net of FIN48 reserves (1,789) (1,426) (846) Change in valuation allowance 31,350 48,364 25,076 Other 1,103 536 541 (Benefit from) provision for income taxes $ (839) $ 535 $ (3,906)
Significant Components of Deferred Tax Assets and Liabilities	Significant components of the Company’s deferred tax assets and liabilities are as follows: As of January 31, 2023 2022 (in thousands) Deferred tax assets: Net operating losses $ 117,735 $ 100,770 Capitalized research and development 25,568 — Allowances and accruals 10,154 8,564 Stock-based compensation 11,549 11,343 Charitable contributions 3,997 4,025 Tax credits 12,105 9,035 Lease liabilities 4,659 6,798 Other 1,519 2,475 Gross deferred tax assets $ 187,286 $ 143,010 Less: valuation allowance (162,865) (122,091) Net deferred tax assets $ 24,421 $ 20,919 Deferred tax liabilities: Deferred commissions $ (12,089) $ (11,156) Intangible assets (11,544) (6,608) Lease assets (3,497) (5,169) Other (324) (113) Gross deferred tax liabilities $ (27,454) $ (23,046) Net deferred tax liabilities $ (3,033) $ (2,127)
Summary of Activity Related to Unrecognized Tax Benefits	The following table summarizes the activity related to the Company’s unrecognized tax benefits: Year Ended January 31, 2023 2022 2021 (in thousands) Balance at beginning of period $ 6,190 $ 5,018 $ 4,043 Additions related to prior years 85 86 29 Reductions related to prior years (18) (70) (8) Additions related to current year 1,304 1,156 591 Additions related to acquired positions 162 — 363 Balance at end of period $ 7,723 $ 6,190 $ 5,018

Geographic Information (Tables)

Geographic Information (Tables)	12 Months Ended
	Jan. 31, 2023
Segment Reporting [Abstract]
Disaggregation of Revenue By Geographic Location	Revenue by location is determined by the billing address of the customer. The following table sets forth revenue by geographic area: Year Ended January 31, 2023 2022 2021 (in thousands) United States $ 283,266 $ 212,829 $ 163,313 International 87,527 68,567 50,243 Total $ 370,793 $ 281,396 $ 213,556

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Narrative (Details)	12 Months Ended
	Jan. 31, 2023 USD ($) segment	Jan. 31, 2022 USD ($)	Jan. 31, 2021 USD ($)	Jun. 25, 2020 USD ($)	Jan. 31, 2020 USD ($)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Number of operating segments | segment	1
Allowance for doubtful accounts	$ 2,014,000	$ 1,809,000	$ 1,188,000
Payment terms, period post invoice date (in days)	30 days
Amortization period for sales commissions for initial contracts that are deferred (in years)	4 years
Deferred contract costs	$ 46,389,000	42,831,000	31,587,000
Amortization of deferred contract costs	19,247,000	14,923,000	10,977,000
Impairment loss in relation to costs capitalized	0	0	0
Capitalized internal-use software costs	4,800,000	4,700,000	1,000,000
Impairment on goodwill and intangible assets	0	0	0
Advertising costs	7,300,000	10,600,000	10,100,000
Convertible senior notes, net	282,908,000	281,069,000
Accumulated deficit	(240,978,000)	(266,975,000)	(366,727,000)		$ (307,938,000)
Impairment loss recorded	0
Additional Paid-in Capital
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Accumulated deficit	(719,816,000)	(616,467,000)	(614,494,000)		(487,008,000)
Accumulated Deficit
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Accumulated deficit	477,246,000	348,823,000	248,110,000		$ 179,207,000
Cumulative Effect, Period of Adoption, Adjustment
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Accumulated deficit			61,736,000
Cumulative Effect, Period of Adoption, Adjustment | Additional Paid-in Capital
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Accumulated deficit			68,478,000
Cumulative Effect, Period of Adoption, Adjustment | Accumulated Deficit
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Accumulated deficit			(6,742,000)
Convertible Senior Notes
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Aggregate principal amount of debt issued				$ 287,500,000
Director
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Revenue from sale of product to related parties	1,300,000	2,500,000	1,100,000
Billings to related parties	$ 1,800,000	$ 2,200,000	1,100,000
Expenditures related to purchases			1,200,000
Cash disbursements			$ 1,100,000
Internal-Use Software Costs
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Estimated useful lives of respective property and equipment assets (in years)	3 years
Minimum
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Estimated useful lives of respective property and equipment assets (in years)	3 years
Maximum
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Estimated useful lives of respective property and equipment assets (in years)	5 years

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Activity Related to Allowance for Doubtful Accounts (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Balance as of beginning of period	$ 1,809	$ 1,188
Charged to bad debt expense	1,063	1,099
Write-offs, net of recoveries	(858)	(478)
Balance as of end of period	$ 2,014	$ 1,809

Summary of Significant Accoun_6

Summary of Significant Accounting Policies - Rollforward of Deferred Contract Costs (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Increase (Decrease) in Capitalized Contract Costs [Roll Forward]
Balance as of beginning of period	$ 42,831	$ 31,587
Additions to deferred contract costs	22,805	26,167
Amortization of deferred contract costs	(19,247)	(14,923)	$ (10,977)
Balance as of end of period	$ 46,389	$ 42,831	$ 31,587

Redeemable Non-Controlling In_3

Redeemable Non-Controlling Interest - Narrative (Details)	1 Months Ended
	May 31, 2022
Variable Interest Entity, Primary Beneficiary
Noncontrolling Interest [Line Items]
Ownership percentage	51%

Redeemable Non-Controlling In_4

Redeemable Non-Controlling Interest - Summary of Activity (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Redeemable Non-Controlling Interest [Roll Forward]
Balance at beginning of period	$ 0
Investment by redeemable non-controlling interest	1,908
Net loss attributable to redeemable non-controlling interest	(802)	$ 0	$ 0
Foreign currency translation adjustments	2	0	$ 0
Balance at end of period	$ 1,108	$ 0

Balance Sheet Components - Comp

Balance Sheet Components - Components of Cash and Cash Equivalents and Investments (Details) - USD ($) $ in Thousands	Jan. 31, 2023	Jan. 31, 2022
Cash and cash equivalents
Cash	$ 67,151	$ 268,091
Money market funds	206,868	73,194
Commercial paper	0	5,500
U.S. Treasury securities	0	3,000
Total cash and cash equivalents	274,019	349,785
Available-for-sale investments
Total available-for-sale investments	202,948	193,571
U.S. Treasury securities
Available-for-sale investments
Total available-for-sale investments	51,387	41,105
Commercial paper
Available-for-sale investments
Total available-for-sale investments	34,798	39,483
Corporate debt securities
Available-for-sale investments
Total available-for-sale investments	108,827	112,983
U.S. Government agency securities
Available-for-sale investments
Total available-for-sale investments	$ 7,936	$ 0

Balance Sheet Components - Carr

Balance Sheet Components - Carrying Value of Investments (Details) - USD ($) $ in Thousands	Jan. 31, 2023	Jan. 31, 2022
Available-for-sale investments
Cost Basis	$ 204,389	$ 194,240
Unrealized Loss, Net	(1,441)	(669)
Recorded Basis	202,948	193,571
U.S. Treasury securities
Available-for-sale investments
Cost Basis	51,400	41,147
Unrealized Loss, Net	(13)	(42)
Recorded Basis	51,387	41,105
Commercial paper
Available-for-sale investments
Cost Basis	34,926	39,528
Unrealized Loss, Net	(128)	(45)
Recorded Basis	34,798	39,483
Corporate debt securities
Available-for-sale investments
Cost Basis	110,063	113,565
Unrealized Loss, Net	(1,236)	(582)
Recorded Basis	108,827	$ 112,983
U.S. Government agency securities
Available-for-sale investments
Cost Basis	8,000
Unrealized Loss, Net	(64)
Recorded Basis	$ 7,936

Balance Sheet Components - Cont

Balance Sheet Components - Contractual Maturity (Details) - USD ($) $ in Thousands	Jan. 31, 2023	Jan. 31, 2022
Adjusted Cost
Due within one year	$ 139,443	$ 154,692
Due between one to five years	64,946	39,548
Cost Basis	204,389	194,240
Fair Value
Due within one year	138,625	154,455
Due between one to five years	64,323	39,116
Fair Value	$ 202,948	$ 193,571

Balance Sheet Components - Addi

Balance Sheet Components - Additional Information (Details)	12 Months Ended
	Jan. 31, 2023 USD ($) security day	Jan. 31, 2022 USD ($) security	Jan. 31, 2021 USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Securities in an unrealized loss position | security	81	69
Securities in a continuous net loss position for 12 months or longer	21	7
Total unrealized loss on available-for-sale securities	$ (1,441,000)	$ (669,000)
Total unrealized loss		700,000
Impairment loss recorded	0
Depreciation and amortization	6,800,000	4,600,000	$ 3,800,000
Capitalized internal-use software	$ 8,800,000	$ 5,200,000

Balance Sheet Components - Prop

Balance Sheet Components - Property and Equipment, Net (Details) - USD ($) $ in Thousands	Jan. 31, 2023	Jan. 31, 2022
Property, Plant and Equipment [Line Items]
Gross property and equipment	$ 40,712	$ 33,697
Accumulated depreciation and amortization	(22,322)	(15,468)
Property and equipment, net	18,390	18,229
Leasehold improvements
Property, Plant and Equipment [Line Items]
Gross property and equipment	15,585	15,392
Computers and equipment
Property, Plant and Equipment [Line Items]
Gross property and equipment	9,426	7,483
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Gross property and equipment	4,730	4,686
Capitalized internal-use software
Property, Plant and Equipment [Line Items]
Gross property and equipment	10,971	6,136
Construction-in-progress
Property, Plant and Equipment [Line Items]
Gross property and equipment	$ 6,000	$ 6,900

Balance Sheet Components Balanc

Balance Sheet Components Balance Sheet Components - Components of Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Jan. 31, 2023	Jan. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accrued professional fees	$ 4,926	$ 3,790
Accrued events	952	463
Accrued hosting and infrastructure	1,384	1,495
Accrued taxes	1,711	1,056
Accrued liabilities, other	2,831	6,836
Accrued expenses and other liabilities	$ 11,804	$ 13,640

Balance Sheet Components Bala_2

Balance Sheet Components Balance Sheet Components - Components of Accrued Compensation (Details) - USD ($) $ in Thousands	Jan. 31, 2023	Jan. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accrued bonuses	$ 15,594	$ 13,480
Accrued compensation, other	26,240	21,847
Accrued compensation	$ 41,834	$ 35,327

Fair Value Measurements (Detail

Fair Value Measurements (Details) - Recurring - USD ($) $ in Thousands	Jan. 31, 2023	Jan. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money market funds	$ 206,868	$ 81,694
Investments	202,948	193,571
Total	409,816	275,265
U.S. Treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments	51,387	44,105
Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments	34,798	44,983
Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments	108,827	112,983
U.S. Government agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments	7,936
Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money market funds	206,868	73,194
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total	206,868	81,694
Level 1 | U.S. Treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments	0	3,000
Level 1 | Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments	0	5,500
Level 1 | Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments	0	0
Level 1 | U.S. Government agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments	0
Level 1 | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money market funds	206,868	73,194
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total	202,948	193,571
Fair value of convertible senior notes	304,800
Level 2 | U.S. Treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments	51,387	41,105
Level 2 | Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments	34,798	39,483
Level 2 | Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments	108,827	112,983
Level 2 | U.S. Government agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments	7,936
Level 2 | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money market funds	0	0
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total	0	0
Level 3 | U.S. Treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments	0	0
Level 3 | Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments	0	0
Level 3 | Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments	0	0
Level 3 | U.S. Government agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments	0
Level 3 | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money market funds	$ 0	$ 0

Business Combinations - Additio

Business Combinations - Additional Information (Details)		12 Months Ended
	Mar. 08, 2022 USD ($) founder	Jan. 31, 2023 USD ($) business	Jan. 31, 2022 USD ($) business	Jan. 31, 2021 USD ($)	Oct. 31, 2022 USD ($)
Business Acquisition [Line Items]
Research and development		$ 134,876,000	$ 95,690,000	$ 64,566,000
Number of business combinations | business		0	0
Catalytic
Business Acquisition [Line Items]
Purchase consideration	$ 68,800,000
Net deferred tax liability recognized in connection with acquisition	1,330,000
Research and development		$ 1,600,000
Rundeck, Inc
Business Acquisition [Line Items]
Tax deductible Goodwill	$ 0
Number of founders | founder	2
Cash held back					$ 3,400,000
Service period (in years)	2 years

Business Combinations - Allocat

Business Combinations - Allocation of Purchase Consideration (Details) - USD ($) $ in Thousands	Jan. 31, 2023	Mar. 08, 2022	Jan. 31, 2022	Jan. 31, 2021
Business Acquisition [Line Items]
Goodwill	$ 118,862		$ 72,126	$ 72,126
Catalytic
Business Acquisition [Line Items]
Cash and cash equivalents		$ 2,506
Accounts receivable and other assets		801
Prepaid and other current assets		841
Intangible assets		21,800
Goodwill		46,736
Accounts payable and other liabilities		(408)
Deferred revenue		(856)
Other tax liabilities		(1,322)
Deferred tax liability		(1,330)
Total purchase consideration		$ 68,768

Business Combinations - Compone

Business Combinations - Components of Identifiable Intangible Assets Acquired (Details) - USD ($) $ in Thousands	Mar. 08, 2022	Jan. 31, 2023	Jan. 31, 2022
Acquired Finite-Lived Intangible Assets [Line Items]
Fair Value		$ 52,127	$ 27,800
Developed technology
Acquired Finite-Lived Intangible Assets [Line Items]
Fair Value		24,800	5,600
Developed technology | Catalytic
Acquired Finite-Lived Intangible Assets [Line Items]
Fair Value	$ 19,200
Useful life (in years)	3 years
Customer relationships
Acquired Finite-Lived Intangible Assets [Line Items]
Fair Value		$ 24,400	$ 21,800
Customer relationships | Catalytic
Acquired Finite-Lived Intangible Assets [Line Items]
Fair Value	$ 2,600
Useful life (in years)	10 years

Goodwill and Acquired Intangi_3

Goodwill and Acquired Intangible Assets - Changes in Carrying Amount of Goodwill (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022
Goodwill [Roll Forward]
Balance as of Beginning of period	$ 72,126	$ 72,126
Goodwill resulting from business combination	46,736	0
Balance as of end of period	$ 118,862	$ 72,126

Goodwill and Acquired Intangi_4

Goodwill and Acquired Intangible Assets - Schedule of Intangible Assets Subject to Amortization (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Cost	$ 52,127	$ 27,800
Accumulated Amortization	(14,903)	(4,667)
Net	37,224	23,133
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Cost	24,400	21,800
Accumulated Amortization	(5,319)	(2,907)
Net	$ 19,081	$ 18,893
Weighted Average Remaining Useful Life	7 years 10 months 24 days	8 years 8 months 12 days
Developed technology
Finite-Lived Intangible Assets [Line Items]
Cost	$ 24,800	$ 5,600
Accumulated Amortization	(8,342)	(1,493)
Net	$ 16,458	$ 4,107
Weighted Average Remaining Useful Life	2 years 3 months 18 days	3 years 8 months 12 days
Trademarks
Finite-Lived Intangible Assets [Line Items]
Cost	$ 400	$ 400
Accumulated Amortization	(400)	(267)
Net	$ 0	$ 133
Weighted Average Remaining Useful Life	0 years	8 months 12 days
Assembled Workforce
Finite-Lived Intangible Assets [Line Items]
Cost	$ 2,527
Accumulated Amortization	(842)
Net	$ 1,685
Weighted Average Remaining Useful Life	1 year 3 months 18 days

Goodwill and Acquired Intangi_5

Goodwill and Acquired Intangible Assets - Additional Information (Details) - USD ($) $ in Millions	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization expense related to intangible assets	$ 10.2	$ 3.5	$ 1.2

Goodwill and Acquired Intangi_6

Goodwill and Acquired Intangible Assets - Schedule of Expected Amortization Expense in Future Periods (Details) - USD ($) $ in Thousands	Jan. 31, 2023	Jan. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
2024	$ 11,224
2025	10,381
2026	3,858
2027	2,440
2028	2,440
Thereafter	6,881
Net	$ 37,224	$ 23,133

Leases - Information About Leas

Leases - Information About Lease on Condensed Consolidated Balance Sheet (Details) - USD ($) $ in Thousands	Jan. 31, 2023	Jan. 31, 2022
Assets
Lease right-of-use assets	$ 13,982	$ 20,227
Liabilities
Lease liabilities	5,904	5,637
Lease liabilities, non-current	$ 12,704	$ 20,912

Leases - Additional Information

Leases - Additional Information (Details)	Jan. 31, 2023	Jan. 31, 2022
Leases [Abstract]
Weighted average remaining lease term (in years)	3 years 9 months 18 days	4 years 9 months 18 days
Weighted average discount rate (as a percent)	3.70%	3.70%

Leases - Information About Le_2

Leases - Information About Leases on Condensed Consolidated Statement of Operations (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Leases [Abstract]
Operating lease expense	$ 5,651	$ 5,574	$ 5,769
Short-term lease expense	1,842	756	879
Variable lease expense	$ 1,363	$ 939	$ 1,325

Leases - Supplemental Cash Flow

Leases - Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Leases [Abstract]
Cash paid for amounts included in the measurement of lease liabilities	$ 7,025	$ 6,319	$ 5,416

Leases - Schedule of Remaining

Leases - Schedule of Remaining Maturities of Lease Liabilities (Details) $ in Thousands	Jan. 31, 2023 USD ($)
Leases [Abstract]
2024	$ 6,482
2025	6,402
2026	2,244
2027	1,910
2028	1,967
Thereafter	1,011
Gross lease payments	20,016
Less: Imputed interest	(1,408)
Total	$ 18,608

Debt and Financing Arrangemen_3

Debt and Financing Arrangements - Additional Information (Details) $ / shares in Units, shares in Millions		12 Months Ended
	Jun. 25, 2020 USD ($) day $ / shares shares	Jan. 31, 2023 USD ($)	Jan. 31, 2022 USD ($)	Jan. 31, 2021 USD ($)	Apr. 30, 2021
Debt Instrument [Line Items]
Net proceeds from debt offering, after deducting initial purchaser discounts and debt issuance costs paid or payable | $	$ 278,200,000
Conversion rate	0.0249507
Initial conversion price (in dollars per share) | $ / shares	$ 40.08
Long-term debt | $		$ 296,485,000
Net cost incurred to purchase capped calls | $	$ 35,700,000	0	$ 0	$ 35,708,000
Capped Calls
Debt Instrument [Line Items]
Initial strike price (in dollars per share) | $ / shares	$ 40.08
Cap price (in dollars per share) | $ / shares	$ 61.66
Number of shares of common stock covered by capped calls (in shares) | shares	7.2
Automatic exercise period for capped calls, trading days	40
Debt Conversion Terms, One
Debt Instrument [Line Items]
Threshold trading days	20
Threshold consecutive trading days	30
Threshold percentage of stock price trigger	130%
Debt Conversion Terms, Two
Debt Instrument [Line Items]
Threshold trading days	5
Threshold consecutive trading days	10
Threshold percentage of product of last reported sales price of common stock and conversion rate on each such trading day	98%
On or after July 6, 2023
Debt Instrument [Line Items]
Threshold trading days	20
Threshold consecutive trading days	30
Threshold percentage of stock price trigger	130%
Convertible Senior Notes
Debt Instrument [Line Items]
Aggregate principal amount of debt issued | $	$ 287,500,000
Stated interest rate	1.25%				1.25%
Event of default, option to accelerate amounts due, minimum percentage of aggregate principal amount of outstanding debt	25%
Long-term debt | $		282,908,000	$ 281,069,000
Issuance costs attributable to company | $		$ 4,600,000
Effective interest rate		1.93%
Convertible Senior Notes | On or after July 6, 2023
Debt Instrument [Line Items]
Redemption, threshold trading days immediately preceding maturity date	41
Redemption price, percentage of principal amount to be redeemed	100%
Convertible Senior Notes | Fundamental Change
Debt Instrument [Line Items]
Redemption price, percentage of principal amount to be redeemed	100%

Debt and Financing Arrangemen_4

Debt and Financing Arrangements - Net Carrying Amount (Details) - USD ($) $ in Thousands	Jan. 31, 2023	Jan. 31, 2022
Liability Component:
Net carrying amount	$ 296,485
Convertible Senior Notes
Liability Component:
Principal	287,500	$ 287,500
Less: unamortized issuance costs	(4,592)	(6,431)
Net carrying amount	$ 282,908	$ 281,069

Debt and Financing Arrangemen_5

Debt and Financing Arrangements - Interest Expense (Details) - Convertible Senior Notes - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Debt Instrument [Line Items]
Contractual interest expense	$ 3,594	$ 3,594	$ 2,157
Amortization of debt discount	0	0	7,104
Amortization of debt discount and issuance costs(1)	1,839	1,804	704
Total interest expense related to the Notes	$ 5,433	$ 5,398	$ 9,965

Commitments and Contingencies -

Commitments and Contingencies - Purchase Obligations (Details) $ in Thousands	Jan. 31, 2023 USD ($)
Operating Lease Obligations
2024	$ 6,482
2025	6,402
2026	2,244
2027	1,910
2028	1,967
Thereafter	1,011
Gross lease payments	20,016
Purchase Commitments
2024	38,065
2025	21,846
2026	1,346
2027	0
2028	0
Thereafter	0
Total	61,257
Senior Convertible Notes
2024	3,594
2025	3,594
2026	289,297
2027	0
2028	0
Thereafter	0
Net carrying amount	296,485
Total
2024	48,141
2025	31,842
2026	292,887
2027	1,910
2028	1,967
Thereafter	1,011
Total	$ 377,758

Deferred Revenue and Performa_3

Deferred Revenue and Performance Obligations - Deferred Revenue (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Increase (Decrease) In Contract with Customer, Liability [Roll Forward]
Deferred revenue, beginning of period	$ 170,224	$ 129,972	$ 92,569
Billings	408,764	321,648	248,279
Deferred revenue assumed in acquisitions	856	0	2,680
Revenue recognized	(370,793)	(281,396)	(213,556)
Deferred revenue, end of period	$ 209,051	$ 170,224	$ 129,972

Deferred Revenue and Performa_4

Deferred Revenue and Performance Obligations - Additional Information (Details) - USD ($) $ in Millions	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Revenue from Contract with Customer [Abstract]
Percent of total revenue recognized from deferred revenue balance (as a percent)	44%	44%	41%
Future estimated revenue related to performance obligations	$ 188

Deferred Revenue and Performa_5

Deferred Revenue and Performance Obligations - Performance Obligations (Details)	Jan. 31, 2023
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-02-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, period	24 months

Common Stock and Stockholders_3

Common Stock and Stockholders' Equity - Additional Information (Details) $ / shares in Units, $ in Thousands		12 Months Ended
	Apr. 11, 2019 purchase_period	Jan. 31, 2023 USD ($) equityIncentivePlan $ / shares shares	Jan. 31, 2022 USD ($) $ / shares shares	Jan. 31, 2021 USD ($) $ / shares shares	Mar. 08, 2022
Subsidiary, Sale of Stock [Line Items]
Number of equity incentive plans | equityIncentivePlan		2
Number of shares authorized for grant (in shares) | shares		28,881,327	23,343,378
Options granted (in shares) | shares		24,882
Number of shares available for grant (in shares) | shares		13,581,239	14,185,048
Weighted average grant date fair value of stock options (in dollars per share) | $ / shares		$ 16.46	$ 18.26	$ 15.16
Aggregate intrinsic value of stock options exercised		$ 50,800	$ 91,000	$ 72,100
Unrecognized compensation cost related to unvested stock options		7,600
Stock-based compensation expense		$ 109,907	$ 70,033	$ 43,231
Shares of common stock issued under the ESPP (in shares) | shares		495,432	345,051	301,842
Minimum
Subsidiary, Sale of Stock [Line Items]
Range of shares to be received (as a percent)		0%
Research and development
Subsidiary, Sale of Stock [Line Items]
Stock-based compensation expense		$ 39,012	$ 23,764	$ 11,095
General and administrative
Subsidiary, Sale of Stock [Line Items]
Stock-based compensation expense		34,264	23,506	15,701
Sales and marketing
Subsidiary, Sale of Stock [Line Items]
Stock-based compensation expense		$ 29,804	19,012	14,733
Stock options
Subsidiary, Sale of Stock [Line Items]
Unrecognized compensation cost related to unvested awards, period for recognition (in years)		1 year 8 months 12 days
RSUs
Subsidiary, Sale of Stock [Line Items]
Unrecognized compensation cost related to unvested awards, period for recognition (in years)		2 years 8 months 12 days
Unrecognized compensation cost related to unvested RSUs		$ 244,000
Employee Stock Purchase Plan
Subsidiary, Sale of Stock [Line Items]
Number of shares available for grant (in shares) | shares		2,971,223
Offering period (in months)	24 months
Number of purchase periods within each offering period | purchase_period	4
Purchase period (in months)	6 months
Purchase price as a percentage of fair market value of stock on the offering date or the purchase date	85%
Stock-based compensation expense		$ 4,900	4,700	5,300
Amount withheld on behalf of employees for future purchase		$ 10,000	$ 9,700	$ 6,200
Purchase price of common stock issued under the ESPP (in dollars per share) | $ / shares		$ 19.93	$ 22.44	$ 19.83
Performance Shares
Subsidiary, Sale of Stock [Line Items]
Vesting period (in years)		3 years
Unrecognized compensation cost related to unvested awards, period for recognition (in years)		9 months 18 days
Unrecognized compensation cost related to unvested RSUs		$ 600
Performance Shares | Maximum
Subsidiary, Sale of Stock [Line Items]
Range of shares to be received (as a percent)		200%			129%
Common Stock
Subsidiary, Sale of Stock [Line Items]
Shares of common stock issued under the ESPP (in shares) | shares		495,432	345,051	301,842

Common Stock and Stockholders_4

Common Stock and Stockholders' Equity - Shares Available for Issuance (Details) - shares	Jan. 31, 2023	Jan. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant (in shares)	13,581,239	14,185,048
Total common stock reserved at end of period (in shares)	32,305,282
Stock options and RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding stock options and unvested RSUs outstanding (in shares)	15,752,820
Number of shares available for grant (in shares)	13,581,239
ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant (in shares)	2,971,223

Common Stock and Stockholders_5

Common Stock and Stockholders' Equity - Stock Option Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022
Number of Shares
Outstanding at beginning of period (in shares)	8,375,866
Granted (in shares)	24,882
Exercised (in shares)	(2,093,704)
Canceled (in shares)	(156,063)
Outstanding at end of period (in shares)	6,150,981	8,375,866
Vested as of end of period (in shares)	5,538,328
Weighted Average Exercise Price
Outstanding at beginning of period (in dollars per share)	$ 9.28
Granted (in dollars per share)	34.22
Exercised (in dollars per share)	5.21
Canceled (in dollars per share)	15.56
Outstanding at end of period (in dollars per share)	10.61	$ 9.28
Vested as of end of period (in dollars per share)	$ 9.23
Weighted Average Remaining Contractual Term
Outstanding	5 years 3 months 18 days	6 years 1 month 6 days
Vested	5 years 1 month 6 days
Aggregate Intrinsic Value
Outstanding	$ 117,986	$ 198,828
Vested	$ 113,852

Common Stock and Stockholders_6

Common Stock and Stockholders' Equity - Assumptions Used to Calculate Fair Value of Employee Stock Option Grants Made (Details)	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate, minimum			0.08%
Risk-free interest rate, maximum			2.39%
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (years)			6 months
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (years)			2 years 1 month 6 days
Employee | Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected dividend yield	0%	0%	0%
Expected volatility, minimum		43.80%	43%
Expected volatility, maximum	47.10%	46.90%	44.10%
Risk-free interest rate, minimum		1.04%	0.20%
Risk-free interest rate, maximum	2.50%	1.35%	0.52%
Employee | Stock options | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (years)			3 years 8 months 12 days
Employee | Stock options | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (years)	6 years 1 month 6 days	6 years 1 month 6 days	6 years 1 month 6 days

Common Stock and Stockholders_7

Common Stock and Stockholders' Equity - Restricted Stock Units and Performance Stock Units Activity (Details)	12 Months Ended
	Jan. 31, 2023 $ / shares shares
Weighted Average Grant Date Fair Value Per Share
Attainment percentage	100%
RSUs
Number of RSUs
Outstanding at beginning of period (in shares) | shares	6,028,201
Granted (in shares) | shares	6,022,637
Vested (in shares) | shares	(1,721,589)
Canceled (in shares) | shares	(2,316,767)
Outstanding at end of period (in shares) | shares	8,012,482
Weighted Average Grant Date Fair Value Per Share
Outstanding at beginning of period (in dollars per share) | $ / shares	$ 34.77
Granted (in dollars per share) | $ / shares	30.81
Vested (in dollars per share) | $ / shares	33.25
Canceled (in dollars per share) | $ / shares	33.26
Outstanding at end of period (in dollars per share) | $ / shares	$ 32.55
Performance Shares
Number of RSUs
Outstanding at beginning of period (in shares) | shares	117,701
Granted (in shares) | shares	767,409
Vested (in shares) | shares	(47,416)
Canceled (in shares) | shares	(46,968)
Performance adjustment for 2021 PSU Awards (in shares) | shares	34,332
Outstanding at end of period (in shares) | shares	825,058
Weighted Average Grant Date Fair Value Per Share
Outstanding at beginning of period (in dollars per share) | $ / shares	$ 41.17
Granted (in dollars per share) | $ / shares	32.64
Vested (in dollars per share) | $ / shares	41.17
Canceled (in dollars per share) | $ / shares	40.71
Performance adjustment for 2021 PSU Awards (in dollars per share) | $ / shares	41.17
Outstanding at end of period (in dollars per share) | $ / shares	$ 33.27

Common Stock and Stockholders_8

Common Stock and Stockholders' Equity - Schedule of Assumptions Used to Calculate Fair Value of Shares to be Granted Under ESPP (Details)	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate, minimum			0.08%
Risk-free interest rate, maximum			2.39%
ESPP | Employee
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected dividend yield	0%	0%	0%
Expected volatility, minimum	44.10%	41.20%	39.20%
Expected volatility, maximum	65.60%	53.90%	61.60%
Risk-free interest rate, minimum	0.11%	0.05%
Risk-free interest rate, maximum	4.62%	1.64%
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (years)			6 months
Minimum | ESPP | Employee
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (years)	6 months	6 months
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (years)			2 years 1 month 6 days
Maximum | ESPP | Employee
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (years)	2 years	2 years

Common Stock and Stockholders_9

Common Stock and Stockholders' Equity - Stock-based Compensation Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 109,907	$ 70,033	$ 43,231
Stock options
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
One-time stock-based compensation expense related to modification of certain option awards			3,100
Cost of revenue
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	6,827	3,751	1,702
Research and development
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	39,012	23,764	11,095
Sales and marketing
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	29,804	19,012	14,733
General and administrative
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 34,264	$ 23,506	$ 15,701

Net Loss per Share - Calculatio

Net Loss per Share - Calculation of Basic and Diluted Net Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Numerator:
Net loss attributable to PagerDuty, Inc.	$ (128,423)	$ (107,455)	$ (68,903)
Denominator:
Weighted average shares used in calculating net loss per share, basic (in shares)	88,721	84,514	79,614
Weighted average shares used in calculating net loss per share, diluted (in shares)	88,721	84,514	79,614
Net loss per share, basic, attributable to PagerDuty, Inc. (in dollars per share)	$ (1.45)	$ (1.27)	$ (0.87)
Net loss per share, diluted, attributable to PagerDuty, Inc. (in dollars per share)	$ (1.45)	$ (1.27)	$ (0.87)

Net Loss per Share - Anti-dilut

Net Loss per Share - Anti-dilutive Securities (Details) - shares shares in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	22,331	21,888	22,656
Shares subject to outstanding common stock awards
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	14,989	14,522	15,149
Shares issuable pursuant to the 2019 Employee Stock Purchase Plan
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	106	71	73
Restricted stock issued to acquire key personnel
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	63	122	261
Convertible senior notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	7,173	7,173	7,173

Income Taxes - Components of Lo

Income Taxes - Components of Loss Before Income Taxes (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Income Tax Disclosure [Abstract]
Domestic	$ (130,971)	$ (111,426)	$ (77,956)
Foreign	907	4,506	5,147
Loss before benefit from (provision for) income taxes	$ (130,064)	$ (106,920)	$ (72,809)

Income Taxes - Components of In

Income Taxes - Components of Income (Loss) Before Income Taxes (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Current
Federal	$ 0	$ 0	$ 0
State	0	0	(41)
Foreign	267	181	452
Total current tax expense	267	181	411
Deferred
Federal	(794)	0	(4,038)
State	(536)	0	(977)
Foreign	224	354	698
Total deferred tax expense (benefit)	(1,106)	354	(4,317)
Provision (benefit from) for income taxes	$ (839)	$ 535	$ (3,906)

Income Taxes - Reconciliation o

Income Taxes - Reconciliation of Provision for Income Taxes (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Income Tax Disclosure [Abstract]
Income taxes computed at U.S. federal statutory rate	$ (27,313)	$ (22,453)	$ (15,291)
State taxes, net of federal benefit	(5,044)	(8,652)	(5,012)
Stock-based compensation	554	(15,423)	(8,443)
Foreign rate differential	300	(411)	69
Tax credits, net of FIN48 reserves	(1,789)	(1,426)	(846)
Change in valuation allowance	31,350	48,364	25,076
Other	1,103	536	541
Provision (benefit from) for income taxes	$ (839)	$ 535	$ (3,906)

Income Taxes - Additional Infor

Income Taxes - Additional Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Tax Credit Carryforward [Line Items]
State taxes, net of federal benefit	$ (5,044)	$ (8,652)	$ (5,012)
Increase in valuation allowance	40,800	64,100
Unrecognized tax benefits that would affect the effective tax rate if recognized	1,000	1,100	1,000
Catalytic
Tax Credit Carryforward [Line Items]
State taxes, net of federal benefit		$ (1,300)
Rundeck, Inc
Tax Credit Carryforward [Line Items]
State taxes, net of federal benefit			$ (5,000)
Federal
Tax Credit Carryforward [Line Items]
Operating loss carryforwards	451,500
Federal net operating loss carryforwards, subject to expiration	70,500
Federal net operating loss carryforwards, not subject to expiration	381,000
Research and development credit carryforwards	11,200
California
Tax Credit Carryforward [Line Items]
Operating loss carryforwards	27,900
Research and development credit carryforwards	6,400
Canada
Tax Credit Carryforward [Line Items]
Operating loss carryforwards	3,200
Research and development credit carryforwards	$ 1,700

Income Taxes - Significant Comp

Income Taxes - Significant Components of Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands	Jan. 31, 2023	Jan. 31, 2022
Deferred tax assets:
Net operating losses	$ 117,735	$ 100,770
Capitalized research and development	25,568	0
Allowances and accruals	10,154	8,564
Stock-based compensation	11,549	11,343
Charitable contributions	3,997	4,025
Tax credits	12,105	9,035
Lease liabilities	4,659	6,798
Other	1,519	2,475
Gross deferred tax assets	187,286	143,010
Less: valuation allowance	(162,865)	(122,091)
Net deferred tax assets	24,421	20,919
Deferred tax liabilities:
Deferred commissions	(12,089)	(11,156)
Intangible assets	(11,544)	(6,608)
Lease assets	(3,497)	(5,169)
Other	(324)	(113)
Gross deferred tax liabilities	(27,454)	(23,046)
Net deferred tax liabilities	$ (3,033)	$ (2,127)

Income Taxes Income Taxes - Sum

Income Taxes Income Taxes - Summary of Activity Related to Unrecognized Tax Benefits (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Balance at beginning of period	$ 6,190	$ 5,018	$ 4,043
Additions related to prior years	85	86	29
Reductions related to prior years	(18)	(70)	(8)
Additions related to current year	1,304	1,156	591
Additions related to acquired positions	162	0	363
Balance at end of period	$ 7,723	$ 6,190	$ 5,018

Geographic Information - Revenu

Geographic Information - Revenue by Location (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	$ 370,793	$ 281,396	$ 213,556
United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	283,266	212,829	163,313
International
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	$ 87,527	$ 68,567	$ 50,243

Geographic Information - Additi

Geographic Information - Additional Information (Details) - Property, Plant and Equipment - Geographic Concentration Risk	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022
United States
Concentration Risk [Line Items]
Concentration risk, percentage	88%	86%
Canada
Concentration Risk [Line Items]
Concentration risk, percentage	10%	14%
PORTUGAL
Concentration Risk [Line Items]
Concentration risk, percentage	1%
United Kingdom
Concentration Risk [Line Items]
Concentration risk, percentage	1%

Restructuring Costs (Details)

Restructuring Costs (Details) - Employee Severance - Employee Restructuring Plan - USD ($) $ in Millions		12 Months Ended
	Jan. 24, 2023	Jan. 31, 2023
Restructuring Cost and Reserve [Line Items]
Number of positions eliminated (as a percent)	7%
Restructuring charges		$ 5

401(k) Plan (Details)

401(k) Plan (Details) - USD ($) $ in Millions			12 Months Ended
	Jan. 01, 2022	Dec. 31, 2021	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Retirement Benefits [Abstract]
Employer matching contribution, percent of each participant's employee contributions (as a percent)	2%	1%
Employer contributions, percent of eligible wages during the period (as a percent)	2%	1%
Expense recognized related to matching contributions			$ 2.6	$ 1.3	$ 0.8